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96% Equity and Market Neutral… Because There Still are Monsters in the Closet 
  
We believe that a market-weighted portfolio is the most appropriate strategy for the Crummer/ 
SunTrust Endowment in the coming year. This is not the time for a more aggressive position 
because there still are monsters in the market‘s closet capable of sending us back into the abyss.  
This economic and market outlook explains our reasoning.  
 
Like the Great Depression, this recession originated in the financial sector, and these recessions 
last longer and recovery is much slower.  There are still more catalysts for crisis out there, 
including the inevitability of rate hikes, increased government spending and taxation, profit-
sapping bank reform, and international turmoil. The biggest threat, however, is Fed risk. Any 
misstep by the Fed as it disentangles itself from the economy will lead to dramatic declines in 
bond prices, posing a threat to the portfolio‘s principal currently invested in bonds. Beyond 
capital preservation, we believe that in the short term the road ahead will be smoother for stocks 
than bonds. As corporate earnings continue to rise, the stock market will also rise. Our action 
plan reflects our economic and market outlook by moving the portfolio to 96% equity in a 
market-neutral allocation, focusing on stock selection, prioritizing quality, looking for exposure 
outside the U.S, and remaining cautious through the coming year. 
 
I. The Economic Recovery: It Is Different This Time 
Normally after a recession the economy bounces back; however, it is different this time. This 
recession was a byproduct of a global financial crisis whereas every recession since the Great 
Depression was the result of business cycles. A recession originating in the financial sector 
causes much longer lead times and, therefore, we are not going to have the recovery of past 
recessions.
1
 According to William Dickens, Distinguished Professor of Economics and Social 
Policy at Northeast University,  
 Normally at the end of a recession, what the Federal Reserve taketh away it can giveth, 
 spurring a recovery. This has been successful in all the postwar recessions, but this time 
 history is of no help, given the unique reasons for the past recession. The two main tools 
 — fiscal stimulus and lower interest rates — have already been deployed and are no 
 longer available.
2
   
 
                                                 
1
 Brown, Craig. "Why Is This Recession Different." Seeking Alpha. N.p., 1 Jan. 2010. Web. 15 Mar 2010. 
<http://seekingalpha.com/article/115204-why-is-this-recession-different>. 
2
 Banham, Russ. "The Shape of Things to Come." CFO Magazine 1 Mar. 2010: n. pag. Web. 15 Mar 2010. 
<http://www.cfo.com/printable/article.cfm/14476856>. 
Economic and Market Outlook 
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The following six economic predictions provide a more detailed view of this slower-paced 
recovery and, ultimately, support our market-neutral position. 
 
 Average economic growth but sluggish in comparison to previous recessions. Since the 
middle of 2008, we have seen a major market rebound—yet it is clear the US economy is not 
out of woods.  Undoubtedly, serious structural problems remain including ongoing consumer 
deleveraging, a banking system slowly facing up to deteriorating loan quality, an increasing 
yet uncertain regulatory environment, still-troubled credit markets and a real estate market 
that may still be recovering for years to come. The outlook is worsened by the sorry state of 
public finances, both at the state and federal levels. Fundamentally, there are still times of 
uncertainty ahead and more catalysts for crisis out there. According to Prudential, the major 
factors for volatility include market concerns about the sustainability of the GDP recovery 
and fears about a double-dip, uncertainty about central bank exit strategies and the fallout 
from potential aftershocks of the financial crisis, such as the recent Greek dance with 
bankruptcy.
3
 The WSJ also reports that a major unknown is how the markets will fare once 
the Fed starts siphoning off some of the unprecedented amounts of liquidity it pumped into 
the financial markets to the support the economy, especially if the Fed moves too soon. Also 
hovering over the markets is a fear that the massive U.S. government deficit will lead to a 
steep decline in the dollar.
4
 Reflecting these structural problems, consumer confidence 
remains low, falling to 46.0 in February from 55.9 in January.
5
 No recovery will be robust or 
sustainable unless consumer demand, which accounts for approximately 70% of US 
economic activity, returns to something like normal levels. 
 
Others do see more light in the dark. BlackRock expects that positive cyclical forces will 
prevail over the structural problems.
6
 Prudential‘s research suggests GDP growth will be 
driven by low interest rates, inventory rebuilding (as demonstrated by the 5.9% U.S. fourth-
quarter GDP growth), improving global trade, and a modest recovery in the housing market.
7
 
Therefore, we predict U.S. economic growth will be at about 3% for 2010, a pace close to the 
long-term average but below that associated with a typical recovery.  
 
 Weak employment growth with gradual declines in the unemployment rate.  After brutal 
job losses in 2009, unemployment appears to be stabilizing around 9.7%. FIX Nevertheless, 
                                                 
3
 Op cit., Praveen 
4
 Lauricella, Tom. "For Rebuilt Markets, A Test in 2010." Wall Street Journal 5 Jan. 2010: n. pag. Web. 15 Mar 
2010. <http://online.wsj.com/article/SB10001424052748704162104574630242432745528.html> 
5
 Sutton, Chavon. "Consumer Confidence tumbles in February." CNNMoney. CNN, 23 Feb. 2010. Web. 15 Mar 
2010. <http://money.cnn.com/2010/02/22/news/economy/consumer_confidence_index/>. 
6
 Doll, Bob. "What's Ahead in 2010: An Investment Perspective." BlackRock. N.p., 1 Jan. 2010. Web. 15 Mar 2010. 
<http://www.wrapmanager.com/images/uploads/blog/BlackRock_WhatsAheadin2010.pdf>. 
7
 Praveen, John. "Global Economic Outlook 2010: The Year Ahead." Prudential International Investment Advisors. 
N.p., 4 Jan. 2010. Web. 15 Mar 2010. 
<http://news.prudential.com/images/65/2010_Prudential_Global_Economic_Outlook_010410_Final>.   
 7 
this same rate was a 26-year high back in September of last year.
8
 According to Dr. Seyfried, 
Crummer Graduate School of Business Professor of Economics, unemployment is likely to 
ease later on in the year.  However, he believes may be several years before we see 
unemployment below 8% in the U.S.
9
  
 
 Continued consumer deleveraging. As Figure 1 depicts, consumers have just begun to 
deleverage the enormous amount of debt they accumulated, but much more running down is 
bound to continue throughout 2010. Dr. Seyfried predicts consumers will be hard pressed to 
spend money while they are paying down debt.
10
  
 
Figure 1
11
 
 
 
 Subdued inflation. According to the Federal Reserve, inflation is likely to remain a non-
issue. Depressed growth in developed countries, high unemployment, and significant levels 
of slack will support easy global monetary policy. Even with slight U.S. employment growth, 
the Fed expects inflation levels to remain muted in 2010.
12
 
 
 Interest rates drift upward, but not quickly. According to many observers, the Fed 
appears convinced the inflation threat is low and is committed to fostering a recovery in both 
the economy and the financial markets. However, long-term rates may rise reflecting rising 
government debt, a gradual removal of the Fed‘s quantitative easing measures, and, perhaps, 
                                                 
8
 "Monetary Policy Report to Congress." Board of Governors of the Federal Reserve System. Federal Reserve 
Board, 24 Feb. 2010. Web. 15 Mar 2010. 
<http://www.federalreserve.gov/monetarypolicy/mpr_20100224_part1.htm>. 
9
 Opinion provided by Dr. William Seyfried, Crummer Graduate School of Business Professor of Economics, on 
February 22, 2010. 
10
 ibid 
11
 "Total Consumer Credit Outstanding (TOTALNS)." Federal Reserve Bank of St. Louis. Web. 15 Mar 2010. 
<http://research.stlouisfed.org/fred2/graph/?s[1][id]=TOTALNS>. 
12
 Op cit., Federal Reserve Board 
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a stronger economy.
13
 Any misstep by the Fed could also lead to a sharp rise in rates. As 
bond finance dictates, even a small unexpected increase in rates leads to declining bond 
prices.  
 
 Corporate earnings rise significantly. In the downturn of 2008, the business sector was 
quick to cut costs, including payrolls, and increase productivity as much as possible. 
According to BlackRock, this trend should continue, significantly improving corporate 
earnings. Prudential similarly foresees margins widening with falling unit labor costs and 
other efficiency gains. Ongoing weakness in the dollar should also help to support earnings, 
especially for firms with greater exposure to international markets.
14
 
 
II. The Capital Markets: Fleeing to Safety, but This Time to Stocks? 
The economic problems looming could toss the market back into anything from a mild to a 
serious downturn, and we assume the next year will not be without difficulties. In addition, 
according to various analysts, the sentiment is that the overall market is now fairly priced. 
Significantly, we believe the risk in bonds outweighs the benefit of their diversification. 
Therefore, we are recommending a significant reduction in the portfolio‘s bond position.  
 
 Recovery Priced, but Stock beat Bonds. Stocks were extremely undervalued during the 
heart of the credit crisis, and today most view them as generally fairly priced based on long-
term trend.
15
 Statistically, the average Price over Book Value of the S&P over the past 30 
years has been 2.41. The current P/BV is 2.45. In November 2009, it was 2.31. Nevertheless, 
we believe that investment opportunities can be found in the current environment, and 
maintain that stocks should outperform bonds and cash. Prudential‘s research suggests stocks 
are still attractively valued relative to bonds. According to Prudential, future gains in the 
equity markets will be driven by: 1) Solid, sustained GDP growth with growth likely to 
surprise on the upside;  2) Low headline & core inflation; 3) Global central banks keeping 
rates on hold near zero, and liquidity remaining plentiful; 4) Strong earnings growth with 
rising revenues, wider margins & improved pricing power. Positive earnings surprises likely, 
and 5) Continued stabilization in financial market conditions and risk appetite improving 
further.  Prudential‘s research also suggests bond yields are expected to rise with solid, 
sustained GDP growth, a reversal in headline inflation from the 2009 disinflation, and an 
increase in risk appetite. In addition, rising interest rates are inevitable as the Fed drains 
liquidity, another negative for bonds.
16
  
 
In addition to the aforementioned fundamental reasons, statistical evidence also points in 
favor of stocks during this period. A yield curve at near record steepness and an uncertain 
                                                 
13
 "Economic and Market Outlook: Monetary and Fiscal have Continued to Weigh on Markets ." J.P. Morgan 
Private Bank 11 Fed. 2010: Print. 
14
 Op cit., Doll 
15
 Op cit., Doll 
16
 Op cit., Praveen 
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timing of rising rates creates a highly unattractive environment for bonds. Moreover, Dr. 
Singleton‘s research provides historical evidence that periods of steep yield curves have 
created a prime opportunity for gains in the stock market.
17
 
In our judgment, the risk in bonds outweighs their diversification potential at this current 
time. The chances are much greater for a loss in the bond market due to the risks of an 
increase in interest rates. Any misstep by the Fed as it disentangles itself from the economy 
will lead to dramatic declines in bond prices, posing a threat to the portfolio‘s principal 
currently invested in bonds. In addition, we believe the stock market current level is 
supportable at a minimum. Dick Bove of Rochdale Securities sees two major reasons for 
continued stock appreciation. Firstly, the world is awash in liquidity: "We still have $40 
trillion, according to my calculations, in terms of worldwide money supply, growing at 6% a 
year," he says. "That's $2.25 trillion of new money created every year; it has to go 
somewhere."
18
 Secondly, risk appetite has returned.  From junk bonds to emerging markets 
to U.S. stocks, Bove says investors are once again chasing returns in riskier assets. Finally, 
our predicted increase in earnings guards against a reversal of the stock market‘s gains. 
 
III. Beyond Market-Neutral: Our Action Plan 
 
Quality is key. We plan to focus on high quality investments. The future of our economy 
remains uncertain; thus, to keep risk low we have instituted a preference for larger cap stocks 
and mature companies with strong free cash flow and a strong balance sheet. According to 
Morningstar‘s equity analysts, ―The opportunities are mostly in large, high-quality stocks. These 
shares are the cheapest from a valuation perspective, and their competitive advantageous should 
position them well in the event of another downturn.‖19 We also favor those companies that have 
responsibly distributed a consistent dividend because this provides evidence of a health and 
stability. Finally, we currently prefer value to growth stocks. Historically, value stocks have 
performed best in past recoveries. Although over the last several months, the opportunities to 
take advantage of undervalued stocks have declined, J.P. Morgan believes that there are still 
many smart buys in the market for value investors.
20
   
 
Looking for exposure outside the U.S.  According to J.P. Morgan, select international markets 
provide stronger economic growth, attractive valuations and potential boost from a weaker 
dollar.
21
 We plan to invest more heavily in multinational companies and ETFs for exposure.  
                                                 
17
 Research provided by Dr. J. Clay Singleton, Crummer Graduate School of Business Professor of Finance, on 
February 22, 2010. 
18
 Gorenstein, Peter. ―Don‘t Stop Believing: Stock Market Rally is ‗Sustainable,‘ Dick Bove Says.‖ Yahoo Finance. 
N.p., 21 March 2010. Web 21 Mar 2010. < http://finance.yahoo.com/tech-ticker/article/445174/Dont-Stop-
Believing:-Stock-Market-Rally-is-%22Sustainable,%22-Dick-Bove-Says>. 
19
 Glaser, Jeremy. "Happy Birthday, Market Rally." Morningstar. N.p., 9 Mar. 2010. Web. 15 Mar 2010. 
<http://news.morningstar.com/articlenet/article.aspx?id=328937>. 
20
 Op cit., J.P. Morgan 
21
 ibid 
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Remember there is no such thing as a free lunch.  The opportunity to make any kind of so-
called ―easy‖ money quickly appears to have come and gone in the downturn and subsequent 
rally of the recent past.  The principles of risk/reward continue to stand true and for at least until 
April 2011, we are likely to see ongoing volatility and heightened dispersion between the 
winners and the losers. In this sort of environment, selectivity will be critical. 
 
Remain cautious—preserve capital. In this time of continued uncertainty, we will maintain 
market sector weightings and concentration on careful stock selection to reduce our downside 
risk and ensure asset preservation. 
 
 In our judgment, a market-weighted portfolio is the best-suited strategy for the 
Crummer/SunTrust Endowment through April 2011 because monsters still exist in the market‘s 
closet.  Our economic and market perspective explains our reasoning. Firstly, this is not a typical 
recession, resulting in a less-than-typical recovery period.  Secondly, from a capital markets 
perspective, Fed risk and uncertainty on the economic front will inevitably lead to volatility in 
the markets and may produce a decline in bond values. In addition, no longer does it appear that 
equities are as grossly underpriced as they were several months ago. Nevertheless, equities stand 
strong against the risks of capital loss associated with bonds at this time. Although it is 
unconventional to hold almost solely equities, we stand in unconventional times.  Beyond 
market-neutral, our action plan reflects our market judgments by prioritizing quality, looking for 
exposure outside the U.S., focusing on stock selection, and remaining cautious during this time. 
We are confident our position will not only ensure asset preservation, but it will allow the 
portfolio to outperform the market. 
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 Research moves down from the economy to sector to company.  
 
 One or two analysts are assigned to cover the S&P economic sectors based on their prior 
knowledge, experience and interest in the sector. Analysts research how their sectors have 
performed in previous similar economic conditions and consult expert forecasts for their sectors. 
Ultimately, they recommend sector holdings and their respective weights within their sector.  
 
 The  portfolio is sector-weighted. Sector budgets were developed by the Managing Director 
based on the S&P 500 sector weights as of March 8, 2010. The Managing Director uses two 
models, Mean-Variance Optimization and Variance-of-Risk, to determine the effect of the 
proposed new weightings and makes appropriate adjustments based on the determined risk/return 
objectives.  
 
 According to the assigned sector budget, analysts critically analyze current holdings in their 
sectors and make buy/hold/sell recommendations on these holdings as well propose additional 
holdings, if applicable.  This year all sectors received additional funds from the proceeds of 
liquidating the bond portfolio. 
 
 A one-year or a long-term focus may be used for holdings as each holding is designated short-or-
long-term.  This gives the next class insight regarding our suggested holding period.  
 
 Companies with attractive relative valuations and strong fundamentals, particularly strong cash 
flow, return on assets, conservative leverage, history of profit retention for funding future 
growth, and soundness of capital management for the maximization of shareholder earnings and 
returns, are selected to provide for superior total return with reduced volatility. 
 
 Fundamental catalysts are necessary for a buy decision; likewise, fundamentals must not be 
performing as expected by previous class for a sell decision. 
 
 The Managing Director makes the final decision on stock selection based on analysts‘ 
recommendations. 
 
 
 
 
 
 
 
Investment Process and Philosophy 
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Uncertainties Ahead. Potential Gains Within Manufacturing Segment. 
 
This highly cyclical sector has benefitted from the improving economy and is positioned for 
further gains, particularly in the manufacturing segment. Unfortunately, we believe there are too 
many lingering uncertainties in the economy for this sector to fully realize these potential gains 
and continue its outperformance.  
 
Overview 
The Consumer Discretionary Sector encompasses those consumer related industries that tend to 
be the most sensitive to economic cycles. Its manufacturing segment includes automotive, 
household durable goods, textiles & apparel and leisure equipment. The services segment 
includes hotels, restaurants and other leisure facilities, media production and services, and 
consumer retailing services. 
 
Strong Performance during economic recovery 
In general, discretionary spending tends to decrease during a recession, which results in poor 
performance for the sector. Therefore, the sector tends to be among the first groups to move 
during a recovery. We saw this play out as it was one of the first sectors to move higher once the 
market began recovering from its trough in March of last year. In 2009, this sector index rose 
41% versus a 26% advance for the 500. The Crummer Portfolio, being roughly 600 bps 
underweight compared to the S&P 500 benchmark, missed out on a proportionate share of this 
sector‘s gains last year.  
 
Potential for continued gains 
The sector could continue to see strong gains if certain macro-economic factors improve. An 
uptick in employment, which is positively correlated with discretionary spending, looks to be 
stabilizing
22
. Also, retailers have cut costs and remain lean which should continue to help profits 
and produce a high level of positive earnings surprises According to Standard & Poor‘s. Lastly, 
recent data from the Fed suggests consumer lending standards have likely peaked which will 
increase consumers‘ ability to spend on discretionary items. 
 
 
 
 
 
                                                 
22
 NPR. (2010, March 5). Tracking U.S. Monthly Unemployment. Retrieved March 12, 2010, from NPR: 
http://www.npr.org 
 
Consumer Discretionary 
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Economic uncertainties still lingering  
The breadth of economic uncertainties around high unemployment, increased savings rate, high 
delinquency of credit, and removal of monetary and government stimulus paint a grim picture for 
consumer spending. Without jobs, consumers won‘t be making money to splurge on 
discretionary items. The current trend of increased personal savings also negatively impacts 
discretionary spending
23. According to the Fed‘s statistics, the loan and credit card delinquency 
rate, which is negatively correlated with discretionary spending, continues to move higher
24
. 
Lastly, some economists believe the ending of government stimulus and removal of monetary 
stimulus could stymie a rebound in consumer spending and dampen economic prospects
25
. For 
the sector to continue its outperformance, these economic uncertainties will need to improve. 
 
Manufacturing segment potential 
To improve the portfolio‘s diversification within the sector, we recommend increasing its 
exposure to the manufacturing segment. We see a catalyst for strong performance due to 
potential pent-up demand, where a slight upturn in demand is likely to translate into a strong 
upswing in production and in manufacturing employment. We believe the automotive industry is 
well positioned to benefit from this pent-up demand. Sales of new automobiles are running at a 
rate of roughly two million below the number of old vehicles that get scrapped each year, 
suggesting that the current sales pace is unsustainably low. Although the automotive industry has 
experienced substantial gains over the past year, we believe these gains were mostly due to 
lessening worries of bankruptcy, suggesting that the pent-up demand is not yet priced into the 
sector. There will also be demand from inventory replenishment. Inventories were drastically cut 
in late 2008 and throughout 2009 after being overloaded with products. The US total business 
inventories/sales ratio at the end of January was 1.25, below its average of 1.39
26
. We also see a 
catalyst in automotive industry. The pent-up demand coupled with inventory replenishment will 
serve as fertile ground for the manufacturing segment to outperform. 
 
Summary 
Although this sector will benefit from an economic recovery, the uncertainties in our economic 
forecast regarding the strength of the recovery will restrain further outperformance. We advocate 
increasing exposure to the manufacturing subsector to improve the portfolio‘s diversification. 
Market-weighting the Consumer Discretionary sector at 10.25% of equity is an increase of more 
than 550 bps from its current level. 
                                                 
23
 U.S. Department of Commerce. (2010, February 26). Comparison of Personal Saving in the National Income and 
Product Accounts. Retrieved March 8, 2010, from Bureau of Economic Analysis: http://www.bea.gov 
24
 Federal Reserve. (2010, February 19). Charge-off and Delinquency Rates. Retrieved March 8, 2010, from Federal 
Reserve Statistical Release: htt://www.federalreserve.gov 
25
 Brad Sorensen, CFA. Director of Market and Sector Analysis. Schwab Center for Financial Research 
26
 Federal Reserve Bank of St. Louis. (2010, March 1). Data List - Inventory. Retrieved March 13, 2010, from 
Economic Research: http://research.stlouisfed.org 
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Detailed Company Overviews  
 
Abercrombie & Fitch Co.
 27
 - HOLD 
Stock Symbol: ANF Market Capitalization: 3.79B 
Last Trade: 43.09 P/E (ttm): 48.97 
52 Week Range: 16.90 – 43.66 EPS (ttm): 0.88 
Dividend Yield: 1.62% Z-Score: 4.072 
Beta: 1.53 Revenue From Abroad: 15% 
Recommended Holding Period: Short-term 
 
We recommend holding shares of ANF. The company is financially strong and will benefit from 
opportunities in the future. However, we suggest remaining on the sidelines as the company 
tweaks its business and reacts to changing consumer preferences. 
 
Abercrombie & Fitch Co. is a specialty retailer that operates stores selling casual apparel, such as 
knit shirts, graphic t-shirts, jeans, woven shirts and personal care and other accessories for men, 
women and kids. The Company operates stores in the United States and Canada as well as retails 
its products over the Internet. 
 
ANF has strong cash flows, a very healthy balance sheet with a current ratio of 2.7, and little 
downside risk with a z-score of 8.1. However, the stock is trading at a premium with a 12-month 
P/E of 48.9. 
 
Although ANF beat 4Q expectations, mostly due to strong growth internationally, the overall 
outlook for the company is unenthusiastic. Strong headwinds in consumer spending have 
reduced top-line sales and deteriorated gross margins, particularly on the domestic front. These 
trends are persisting as the company continues to be forced into running unplanned markdowns, 
pushing many new products straight to clearance, and further reducing Average Unit Retail 
(AUR) prices. ANF will remain challenged throughout the next year as it continues to realign its 
business offering to changing consumer preferences. While international expansion represents a 
significant opportunity, there is little evidence of a turnaround in process at this point in time.  
 
 
 
 
 
 
 
 
                                                 
27
 Summary obtained from Bloomberg. Data obtained from Brean Murray, Carret & Co. Equity Research, Barrons, 
Bloomberg, and NetAdvantage. 
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Walt Disney Co
28
. - HOLD 
Stock Symbol: DIS Market Capitalization: 65.30 B 
Last Trade: 33.69 P/E (ttm): 19.14 
52 Week Range: 17.01 – 33.81 EPS (ttm): 1.76 
Dividend Yield: 1.04% Z-Score: 2.598 
Beta: 1.15 Revenue From Abroad: 24% 
Recommended Holding Period: Long-term 
 
We give Disney a hold rating. Overall, there seems to be a balance of positives and negatives 
that lead us to a neutral outlook on the company.   
 
The Walt Disney Company, an entertainment company, conducts operations in media networks, 
studio entertainment, theme parks and resorts, consumer products, and Internet and direct 
marketing. The Company produces motion pictures, television programs, and musical 
recordings, as well as publishes books and magazines. Disney also operates ABC radio and 
television and theme parks. 
 
The stock‘s P/E multiple is slightly unfavorable compared to its peers. The recent acquisition of 
Marvel is expected to result in mid-single digit EPS dilution in FY 10 (after repurchasing nearly 
60 million shares issued in the transaction).  
 
The company has shown broad-based improvements across all its core businesses which has led 
to strong recent earnings. Recent changes in management, re-positioning of creative resources 
and improvements in cost structure can help provide above-average earnings growth for the 
company. Profitability has improved and looks to be sustainable due to restructuring efforts, 
despite lower revenues. Park attendance has grown 4% over the past quarter. However, DIS has 
increased promotional activities in order to sustain attendance momentum as occupancy rates 
worsen. Also, cable programming costs, one of the single biggest expense items for the 
company, were up about 9% last quarter, the fourth straight quarter of increased cable costs. 
These negatives seem to balance out the positives. Furthermore, increasing exposure to this 
highly cyclical stock would bring excessive risk to our portfolio, considering our grim economic 
outlook.  
 
 
 
 
 
 
 
                                                 
28
 Summary obtained from Bloomberg. Data obtained from BMO Capital Markets, Barrons, Bloomberg, and 
NetAdvantage. 
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McDonald’s Corp.29 – INCREASE POSITION 
Stock Symbol: MCD Market Capitalization: 70.51 B 
Last Trade: 65.53 P/E (ttm): 15.94 
52 Week Range: 51.36 – 65.98 EPS (ttm): 4.11 
Dividend Yield: 3.36% Z-Score: 5.785 
Beta: 0.63 Revenue From Abroad: 65% 
Recommended Holding Period: Long-term 
 
We recommend buying shares of MCD. The company has an attractive P/E multiple, a strong 
dividend, and is a defensive play which aligns well with our economic outlook. 
 
McDonald's Corporation operates and franchises fast-food restaurants worldwide. The 
Company's franchised and company operated fast food restaurants offer a variety of low price 
fast foods in locations around the world. 
 
The stock has a strong P/E analysis, trading at 15.9x compared to its sub-industry‘s ratio of 
28.3x. The $2.20 per share annual cash dividend is an additional attraction to owning the shares. 
Analysts view MCD as an excellent low risk/absolute return opportunity due to a 15x P/E based 
on 2010 estimates, compared to its 15-16x long-term average, and a 5% FCF yield. 
 
MCD has successfully navigated through lingering economic difficulties and is up 16.08% over 
the past six months compared to the Restaurants sub-industry gain of 11.87%. Furthermore, the 
shares are seen as a defensive play against further risks to a global economic rebound, which 
aligns well with our economic outlook. Key risks to our recommendation include higher than 
expected food costs, poor customer acceptance of MCD‘s new menu offerings, and exchange 
rate risk in light of MCD‘s substantial international business. 
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 Summary obtained from Bloomberg. Data obtained from Morgan Stanley Research, Barrons, Bloomberg, and 
NetAdvantage. 
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Staples, Inc.
30
 - HOLD 
Stock Symbol: SPLS Market Capitalization: 17.07 B 
Last Trade: 23.42 P/E (ttm): 22.96 
52 Week Range: 15.51 – 26.00 EPS (ttm): 1.02 
Dividend Yield: 1.54% Z-Score: 3.697 
Beta: 0.78 Revenue From Abroad: 33% 
Recommended Holding Period: Long-term 
 
We recommend holding shares of Staples. The company is positioned to benefit from improving 
labor markets. We believe there are too many lingering uncertainties in the economic recovery at 
this point in time which will prevent the stock from outperforming in 2010. However, we 
recommend holding shares of SPLS due to the added diversification it brings to the sector and 
exposure it gives to the anticipated increase in business spending. 
 
Staples, Inc. retails office supplies, furniture, and technology. The Company‘s customers include 
consumers and businesses in the United States, Canada, the United Kingdom, and Germany. 
Staples serves its customers through office superstores, mail order catalogs, the Internet, and a 
contract business. 
 
The stock looks to be fully valued. Shares are trading at nearly 18x S&P‘s FY 11 EPS estimate. 
However, the company has a strong balance sheet and significant free cash flow generation. 
 
SPLS is the largest and best operator in its sub-industry with one of the deepest management 
teams in all of retail. The company will eventually benefit from being highly correlated to 
improving labor markets. Although consumer and government spending is predicted to be weak, 
the prospects of business spending is much more favorable. A recovery in the top line should 
lead to accelerating margin trends given the synergies extracted from the CXP integration, a 
favorable product mix, and cost leverage from increased sales. However, we remain cautious due 
to the company‘s high correlation with the macroeconomic environment, which contains many 
uncertainties. 
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 Summary obtained from Bloomberg. Data obtained from J.P. Morgan Equity Research, Barrons, Bloomberg, and 
NetAdvantage. 
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Autoliv, Inc.
31
 - BUY 
Stock Symbol: ALV Market Capitalization:  
Last Trade: 48.33 P/E (forward): 10.3 
52 Week Range: 15.33 – 49.00 EPS (ttm): -0.05 
Dividend Yield: N/A Z-Score: 2.338 
Beta: 1.97 Revenue From Abroad: 77% 
Recommended Holding Period: Long-term 
 
We recommend buying shares of ALV due to our prediction of a strong automotive recovery in 
2010. 
 
Autoliv, Inc. develops and manufactures automotive safety systems for automotive 
manufacturers. The Company's products include seat belts, airbags, anti-whiplash seats, child 
restraints, and leg protection equipment. Autoliv tests cars and products at crash test tracks in 
several countries. 
 
ALV currently trades at a 10.3x P/E on 2012 based on J.P. Morgan‘s 2012 EPS estimate of 
$4.25. We believe a premium valuation is reasonable given the above average growth outlook for 
automotive safety products. Analysts expect a strong 20% rebound in sales for 2010, after a 21% 
decline in 2009. Furthermore, Autoliv has a sound balance sheet and strong cash flow generation 
and should emerge from the downturn as a stronger player. 
 
ALV has maintained a stable market share globally and is well positioned to tap huge market 
potential by expanding into low-cost countries and make major acquisitions. The company has 
the benefit of a regulatory tailwind from the increasing importance of vehicle safety needs. Their 
heavy exposure in emerging markets offers strong upside with tightening safety standards across 
all regions as markets evolve. Downside risks include the duration of the global automotive 
downturn exceeding expectations and high product liability risk, making the company vulnerable 
to lawsuits. However, the highly cyclical risks associated with the company should be offset by 
rising demand for safety equipment in vehicles. 
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 Summary obtained from Bloomberg. Data obtained from J.P. Morgan Equity Research, Barrons, Bloomberg, and 
NetAdvantage. 
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Hasbro Inc
32
. - BUY 
Stock Symbol: HAS Market Capitalization: 5.12 B 
Last Trade: 37.57 P/E (ttm): 15.40 
52 Week Range: 22.27 – 38.82 EPS (ttm): 2.48 
Dividend Yield: 2.62% Z-Score: 4.612 
Beta: 1.13 Revenue From Abroad: 40% 
Recommended Holding Period: Long-term 
 
We recommend buying shares of HAS. The company has transformed itself to adapt to 
technological advancements and will also benefit from a deep pipeline of upcoming movies. 
 
Hasbro, Inc. designs, manufactures, and markets toys, games, interactive software, puzzles, and 
infant products in the United States and internationally. The Company's products include a 
variety of games, including traditional board, card, hand-held electronic, trading card, role-
playing and DVD games, as well as electronic learning aids and puzzles as well as dolls and 
action figures. 
 
The stock looks reasonably priced at 15 times 2010 earnings, but about 12 times 2011 earnings. 
It has a very strong balance sheet with a debt-to-total capital ratio of 42%. It recently lifted its 
dividend to $1 a share, for a yield of 2.6%. 4Q09 EPS was up 77% Y/Y. Sales growth is 
expected to continue in 2010, generated from a new robust product line. 4Q09 gross margins 
expanded 260 bps Y/Y due to fewer markdowns and lower costs. These improvements look 
sustainable going forward as previously negotiated vendor terms should offset potential cost 
increases. 
 
The company has recently transformed its business model by using new forms of technology to 
reach consumers. The company has a deal in 2010 with Electronic Arts to convert properties 
such a Monopoly to electronic formats, including the iPhone. Upcoming movies that Hasbro 
controls and has licensing arrangements for include Iron Man II, Toy Story III, and Transformers 
III. Hasbro is also boosting its presence internationally and should benefit from stronger global 
sales. Key risks include dependency on licensed brands, foreign currency translations, product 
recalls, and dependency on five largest customers which account for over 50% of its business. 
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 Summary obtained from Bloomberg. Data obtained from Morgan Joseph Equity Research, Barrons, Bloomberg, 
and NetAdvantage. 
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Summary of Portfolio Allocation Changes 
 
Holding No. of 
Shares As of 
4/12/10 
Proposed 
No. of 
Shares  
Mkt Value 
As of 4/12/10 
Proposed 
Mkt Value   
AMZN 30 75 $4,236 $14,422 
MCD 125 150 $8,566 $18,639 
ALV 0 150 $0 $8,059 
HAS 0 275 $0 $10,810 
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Value - Here Yesterday. Gone Today.  
 
Because of our conservative economic outlook and our belief that most of the value is already 
priced in this sector, market weighting consumer staples is appropriate. Even so, innovations like 
CVS‘ ―Minute Clinic‖ and Church & Dwight‘s Oxi Clean Max Force suggest there are still some 
opportunities in this sector.  
 
Undervalued in ’08–Fairly valued in ’10 
Consumer staples can be regarded as a defensive sector that has shown resilience during 
recessionary periods. For example, in 2008 the S&P had a return of -34.47% while the consumer 
staples sector had only a -15.43% annual return, not only outperforming the market substantially 
but also the 9 others sectors by a range of 7.4% to 39.9%. However, since recovery in the market 
began in March of ‘09, we have seen a reversing trend. The S&P began to significantly 
outperform the consumer staples sector because all of the value had already been found in 
consumer staples securities. Now that the market has calmed down in early ‘10 we are left to 
believe that the sector is fairly valued. 
 
Opportunities in Drug Retail & Household Products 
The fundamental outlook for the drug retail industry is favorable for the next 12 months 
according to analysts at Standard & Poor‘s. In 2009, the S&P Drug Retail Index outperformed 
the S&P 500 by 1.4% due to the increased importance investors placed on the long term view of 
the industry. Analysts at UBS believe for this growth to continue in 2010 due to consolidation 
within the industry, improvements in merchandise management, a growing presence of in-store 
clinics, as well as favorable demographic trends. These factors will benefit the national chains in 
particular by expanding margins and encouraging traffic into stores.   
The fundamental outlook for household products remains neutral according to analysts‘ 
consensus. Prices in key commodities such as natural gas, oil, and resin are expected to rise, 
accelerating cost pressures in the industry. Competition in the industry is high and demand in 
developed markets is low, causing firms to focus on product innovation to increase sales 
domestically and venture into emerging markets internationally. However, there is value to be 
found in the market with companies such as Church & Dwight showing organic sales growth of 
nearly 5% due to the firm‘s expanding line of value products and increasing awareness of its 
operating efficiencies.  
 
Fair value equals market weight 
Due to the rather neutral fundamental outlook for the next 12 months, it is recommended to 
market weight the consumer staples sector as it relates to asset allocation in the Crummer 
SunTrust portfolio. Prior to making final decisions for the portfolio, it is advised to seek 
Consumer Staples 
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opportunities in the drug retail and household product sub-industries as these areas show the 
largest opportunity for growth in the consumer staples sector. 
 
Proposed Changes in Consumer Staples Portfolio 
According to our initial research and findings as well as analysts‘ opinions, the current holdings 
in the consumer staples portfolio all look promising for the upcoming year. However, other 
opportunities exist outside of these holdings. In order to take advantage of these opportunities, 
we recommend selling 230 shares of Proctor & Gamble as it accounts for nearly half of our 
current consumer staples‘ holdings. We also recommend selling 250 shares of SYSCO Corp. 
because the outlook for food distributors is quite neutral as well as the need to further diversify 
within the consumer staples sector.  
 
From selling shares of these two securities, we now have an additional $21,888.50 to reinvest, 
$14,421 from PG and $7,467.50 from SYY respectively. With this additional capital, we 
recommend purchasing 146 shares of Church & Dwight Co, resulting in an investment of 
$9,898.89. The remaining capital allocated to this sector is recommended to be invested into 
CVS based on the firm‘s promising outlook. This investment brings the 100 shares previously 
owned in the portfolio to 300 shares for the upcoming year, an investment of $7,396. 
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Detailed Company Overviews
33
  
 
Avon Products, Inc. – HOLD 
Stock Symbol: AVP Market Capitalization: 13.69B 
Last Trade: 32.61 P/E (ttm): 22.24 
52 Week Range: 17.24 – 35.65 EPS (ttm): 1.44 
Dividend Yield: 2.75%  Z-Score: 4.511 
Beta: 1.46 Revenue from Abroad: 77% 
 
Avon Products, Inc. manufactures and markets beauty and related products worldwide. Its 
product categories include Beauty, Fashion, and Home. Beauty consists of cosmetics, fragrances, 
skin care, and toiletries. Fashion consists of fashion jewelry, watches, apparel, footwear, and 
accessories. Home includes gift and decorative products, housewares, entertainment and leisure, 
and children‘s and nutritional products. Avon Products markets its products through direct 
selling and independent representatives, as well as through distributorships. The company was 
founded in 1886 and is based in New York, New York. 
 
In 2010 Avon should expect to see cost saving benefits of roughly $200 million from its multi-
year restructuring plans that were implemented in both 2005 and 2009. The plan initiated last 
year entails reorganizing and downsizing of the organization while the 2005 plan focuses on 
increasing international manufacturing and supply chain efficiencies. The benefits from these 
restructuring efforts were visible in 2009; however the cost savings were masked due to negative 
foreign currency translation and economic weakness.  
 
The forecasts for a positive swing in foreign currency transaction effects in the upcoming year 
will allow Avon to see these cost savings benefits, which will be reinvested in marketing, R&D, 
and incentivizing the firm‘s sales force. In addition to experiencing the cost savings, positive 
foreign currency translation should allow for widening operating margins in 2010. Sales growth 
is forecasted to be 8% in 2010, led by Europe, Latin America, Africa, and the Middle East while 
sales lag in both North America and China. 
 
 
                                                 
33
 All financial statistics were from Financial Visualizations, Research Insight, and Yahoo! Finance. All research 
was based on Yahoo! Finance, Net Advantage and Value Line. 
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Coca Cola Company – HOLD 
Stock Symbol: KO Market Capitalization: 122.98B 
Last Trade: 54.54 P/E (ttm): 18.21 
52 Week Range: 39.98 – 58.63 EPS (ttm): 2.93 
Dividend Yield: 3.30%  Z-Score: 5.851 
Beta: 0.59 Revenue from Abroad: 70% 
 
The Coca-Cola Company engages in the manufacture, distributing, and marketing of 
nonalcoholic beverage concentrates and syrups worldwide. It principally offers sparkling and 
still beverages. The company‘s sparkling beverages include nonalcoholic ready-to-drink 
beverages with carbonation, such as energy drinks, carbonated waters, and flavored waters. 
Coke‘s still beverages consist of nonalcoholic beverages without carbonation, including non-
carbonated waters, flavored waters and enhanced waters, juices and juice drinks, teas, coffees, 
and sports drinks. The Coca-Cola Company also offers fountain syrups, syrups, and concentrates, 
such as flavoring ingredients and sweeteners. The company markets its nonalcoholic beverages 
under the Coca-Cola, Diet Coke, Fanta, and Sprite brand names. It sells its finished beverage 
products primarily to distributors, and beverage concentrates and syrups to bottling and canning 
operators, distributors, fountain wholesalers, and fountain retailers. The Coca-Cola Company 
was founded in 1886 and is headquartered in Atlanta, Georgia.  
 
Coca-Cola is expected to show growth in both earnings and cash flow for 2010 due to sales 
transitioning from flat line to top line growth. Benefits in sales growth are a result from pricing 
gains, new product contributions, and positive foreign currency translation. KO as with most 
major concentrate companies however should not expect to outperform the broader market over 
the upcoming year. The forecasted higher pricing for much of the firm‘s carbonated soft drink 
will undoubtedly increase sales levels, however volume growth for these beverages may be 
restrained by higher pricing. Analysts at S&P recommend a ―buy/hold‖ on Coca-Cola. 
  
 
 25 
Colgate-Palmolive Co. – HOLD 
Stock Symbol: CL Market Capitalization: 41.55B  
Last Trade: 84.95 P/E (ttm): 19.26 
52 Week Range: 55.91 – 85.84 EPS (ttm): 4.37 
Dividend Yield: 2.52% Z-Score: 6.586 
Beta: 0.51 Revenue from Abroad: 34% 
 
Colgate-Palmolive Company, together with its subsidiaries, is a global manufacturer and 
marketer of consumer products. The company operates in two segments: Oral, Personal, and 
Home Care; and Pet Nutrition. Some of the notable brands associated with the Oral, Personal, 
and Home Care segment include Colgate, Palmolive, Mennen, Speed Stick, Lady Speed Stick, 
Softsoap, and Irish Spring. The brands within the Pet Nutrition segment include Hill‘s Science 
Diet, and Hill‘s Prescription Diet names. Colgate-Palmolive sells its products to wholesale and 
retail distributors, and to veterinarians and specialty pet retailers. The company was founded in 
1806 and is headquartered in New York, New York. 
 
Analysts recommend a ―buy‖ on shares of Colgate-Palmolive as of early 2010 because the 
current stock price does not fully reflect the firm‘s above industry average growth forecasts. 
Unlike 2009, were sales were flat and a negative 6.5% foreign exchange effect was seen, 
forecasts for 2010 indicate sales growth of 6.0% and a modest benefit from foreign currency 
exchange. However, the recent changes in the Venezuelan bolivar are expected to negatively 
affect 2010‘s results.  
 
Although the firm's four-year restructuring effort was completed by the end of 2008, expect to 
see potential additional benefits in 2010. These benefits will be reinvested into R&D and 
marketing, with more of the firm‘s resources being allocated to developing markets. The firm‘s 
strength lies in its products, which are basic consumer staples such as toothpaste and soap. In 
2009, consumer consciousness rose, causing many to trade value brands and private label goods. 
This trend is forecasted to remain for the majority of 2010 as increases in consumer spending 
will be focused more in cyclical industries, which may limit CL‘s sales growth. 
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CVS Caremark Corp. – INCREASE POSITION 
Stock Symbol: CVS Market Capitalization: 48.15B 
Last Trade: 35.19 P/E (ttm): 13.53 
52 Week Range: 26.40 – 37.84 EPS (ttm): 2.56 
Dividend Yield: 1.01% Z-Score: 3.063 
Beta: 0.72 Revenue from Abroad: 0% 
 
CVS Caremark Corporation, a pharmacy services company, provides prescriptions and related 
health care services in the United States. The company operates through two segments, 
Pharmacy Services and Retail Pharmacy. The Pharmacy Service segment provides a range of 
prescription benefit management services. The Retail Pharmacy Segment sells prescription 
drugs, over-the-counter drugs, beauty products and cosmetics, photo finishing, seasonal 
merchandise, greeting cards, and convenience foods through its pharmacy retail stores, and 
online. As of December 31, 2008, it operated 6,923 retail drugstores located in 41 states and the 
District of Columbia, 560 retail health care clinics in 27 states, 58 retail specialty pharmacy 
stores, 19 specialty mail order pharmacies, and 7 mail service pharmacies located in 26 states of 
the United States, Puerto Rico, and the District of Columbia. The company was founded in 1892 
and is headquartered in Woonsocket, Rhode Island. 
 
Margins are expected to rise for CVS in the upcoming year due to the quick turnaround of its 
acquired drug stores on the west coast, reduced investment costs for the growing presence of in-
store Minute Clinics, and favorable demographic trends. For this reason, analysts place a ―buy‖ 
recommendation for CVS. However, prescription retail sales are expected to fall due to 
significant client losses in the firm‘s pharmacy benefit management business segment, hindering 
earnings growth in 2010. Significant long-term synergies from recent drugstore acquisitions 
should be realized by the end of 2010 and into 2011 as well as the rollout of mail service 
programs, resulting in strong EPS growth in the longer term. 
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Proctor & Gamble Co. – DECREASE POSITION 
Stock Symbol: PG Market Capitalization: 183.92B 
Last Trade: 63.88 P/E (ttm): 17.89 
52 Week Range: 44.18 – 63.89 EPS (ttm): 3.54 
Dividend Yield: 2.78% Z-Score: 2.707 
Beta: 0.58 Revenue from Abroad: 41% 
 
The Procter & Gamble Company (P&G), together with its subsidiaries, provides globally 
branded consumer goods products worldwide. The company operates in three global business 
units (GBU): Beauty, Health and Well-Being, and Household Care. Some of the most notable 
brands include Head & Shoulders, Pantene, CoverGirl, Braun, Gillette, Mach 3, Crest, Oral-B 
Iams, Tide, Bounty, and Pampers to name a few. The company sells its products in 
approximately 180 countries through mass merchandisers, grocery stores, membership club 
stores, drug stores, department stores, salons, and high-frequency stores. P&G was founded in 
1837 and is headquartered in Cincinnati, Ohio. 
 
Proctor & Gamble remains a ―buy‖ recommendation by the consensus of analysts, mainly due to 
the firm‘s tiered product portfolio, consistent operating results, innovation, and geographic 
scope. Sales growth is expected to be modest with more benefits being seen in the value segment 
and from the acquisition of Gillette. Look for growth in major brand categories from the 
introduction of new and innovative products as well from the continuing trend of offering more 
products to developing markets. This stock will remain a solid addition to the portfolio even 
though the dividend yield decreased from 3.32% in the beginning of 2009 to the current yield of 
2.78%. 
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Sysco Corp. – DECREASE POSITION 
Stock Symbol: SYY Market Capitalization: 16.97B  
Last Trade: 28.95 P/E (ttm): 14.92 
52 Week Range: 21.08 – 29.21 EPS (ttm): 1.92 
Dividend Yield: 3.49% Z-Score: 6.492 
Beta: 0.70 Revenue from Abroad: 9% 
 
SYSCO Corporation, through its subsidiaries, markets and distributes a range of food and related 
products primarily for the foodservice industry. It distributes a line of frozen foods, a line of 
canned and dry foods, along with supplying various non-food items and cleaning supplies to 
restaurants, hospitals and nursing homes, schools and colleges, and hotels and motels. As of June 
28, 2008, it operated 180 distribution facilities throughout the United States and Canada. The 
company was founded in 1969 and is headquartered in Houston, Texas. 
 
SYSCO‘s largest business segment, restaurant sales, which accounted for 62% of 2009 sales, 
remains under pressure from weak consumer discretionary spending. For this reason, sales fell 
by 1.8% in 2009, causing analysts at S&P to downgrade their recommendation to a ―hold‖. Sales 
are expected to be flat in 2010 and to slightly increase to 3% in 2011. However, during the 
recession, SYY has been able to maintain its market share in the industry due to the quality of 
the firm‘s products and services. Look for operating margins to slightly increase in 2010 due to 
productivity gains that will be realized by adopting an SAP platform to the firm‘s enterprise 
system.  
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Church & Dwight Co. Inc. – BUY 
Stock Symbol: CHD Market Capitalization: 4.84B  
Last Trade: 68.79 P/E (ttm): 20.09 
52 Week Range: 49.65 – 68.51 EPS (ttm): 3.41 
Dividend Yield: 0.82% Z-Score: 3.535 
Beta: 0.34 Revenue from Abroad: 16% 
 
Church & Dwight was founded in 1846 as a marketer of sodium bicarbonate (more commonly 
known as baking soda) for use in home baking. Today, CHD's baking soda-based products are 
used as refrigerator and freezer deodorizers, scratchless cleaners and deodorizers for kitchen 
surfaces and cooking appliances, bath additives, dentifrices, cat litter deodorizers and swimming 
pool pH stabilizers. CHD's business is divided into three primary segments: Consumer Domestic, 
Consumer International, and Specialty Products.  
 
A new addition to the portfolio this year, Church & Dwight Co. is known for its iconic baking 
soda brand Arm & Hammer as well as the popular line of Oxi Clean products. The firm has 
expanded its products line and sales volumes over the recent years. Sales for CHD in 2009 rose 
4.1% while the firm‘s organic sales grew by 4.7%. CHD has strategically expanded the scope of 
its value pricing segments during the economic turmoil of the last 2 years and is forecasting to 
continue this trend into the future. 
 
The firm‘s operating margin is expected to widen by nearly 200 basis points in 2010. The main 
catalyst for this margin growth is that gets to benefit from its first full year at its new and highly 
efficient liquid laundry detergent manufacturing plant. Moderation in commodity cost pressures 
as well as slightly positive foreign currency translation for the year also aid in the CHD‘s margin 
growth. 
 
Analysts believe the current valuation inadequately reflects the firm‘s above average earnings 
growth consistency as well as its attractive future growth prospects. For this reason, the 
consensus of analysts gives Church & Dwight Co. a ―strong buy‖ recommendation. 
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Summary of Portfolio Allocation Changes 
 
Holding No. of 
Shares As of 
4/12/10 
Proposed 
No. of 
Shares  
Mkt Value 
As of 4/12/10 
Proposed 
Mkt Value  
CHD 0 146 $9,898 $9,898 
CVS 100 300 $3,698 $11,094 
PG 600 370 $37,620 $23,199 
SYY 500 250 $14,935 $7,467 
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A Solar Subsidy Eclipse  
 
Barack Obama‘s administration has made a move towards reducing dependence on foreign oil 
and to replacing our dependence with renewable forms of energy. However, in the face of 
looming budget deficits it is unlikely that the subsidies that have financed alternative energy will 
continue.  Currently, the US is ―between Scylla and Charybdis‖ with the rising challenges in 
meeting the costs of health care, national defense and social security, energy subsidies do not 
stand a chance.  The projected increasing costs of health care will drive the US deficit to 
unimaginable heights
34
, and will cause other areas of government concern to be cut. 
 
Long-term we expect that as oil reserves begin to dry up, reflected in higher prices of oil, the 
market will move towards pursuing forms of renewable energy. According to some economists 
while the issue facing companies today is credit-worthiness and the de-leveraging of balance 
sheets, the issue of tomorrow is the environment. This combo induces an encouraging future in 
the renewable energy market, but only for those who can afford to wait.  President Obama has 
cited modeling our move towards solar energy after the German‘s, arguable the world‘s leader in 
solar energy.  However, the German solar energy market was financed by subsidies, and these 
subsidies are currently on the chopping block across Germany—modeling the US after Germany 
a little more than we would have liked!  In short, renewable energy is a good idea and some 
would say the ―right thing‖, but this is not the right time.   
 
We recommend market weighting the energy sector because pending US legislation will 
negatively affect current subsidies to both oil and alternative energy companies. Leaving us to 
the adage of, ―Nothing good, nothing bad, everything is up in the air.‖  Given our outlook, 
indexing may seem like a reasonable choice; however, based on the cost basis of the holdings 
now would not be a wise time to sell.   
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Detailed Company Overviews  
 
Exxon Mobile Corp. – HOLD 
Stock Symbol: XOM Market Capitalization: 314.15B 
Last Trade: 68.61 P/E (ttm): 17.25 
52 Week Range: 63.56 – 76.54 EPS (ttm): 3.98 
Dividend Yield: 2.50% Z-Score: 3.52 
Beta: 0.43 Revenue From Abroad: 70.2% 
Recommended Holding Period: Long-term 
 
Exxon Mobil Corporation engages in the exploration, production, transportation, and sale of 
crude oil and natural gas. The company also engages in the manufacture of petroleum products, 
and transportation and sale of crude oil, natural gas, and petroleum products. It manufactures and 
markets commodity petrochemicals, including olefins, aromatics, polyethylene and 
polypropylene plastics, and other specialty products. The company also has interests in electric 
power generation facilities. As of December 31, 2008, it operated 16,286 gross wells. Exxon 
Mobil Corporation primarily operates in the United States, Canada, Europe, Africa, the Asia 
Pacific, the Middle East, Russia/Caspian region, and South America. The company was formerly 
known as Exxon Corporation and changed its name to Exxon Mobil Corporation in November 
1999. Exxon Mobil Corporation was founded in 1870 and is based in Irving, Texas.  
 
Exxon Mobil could not escape the effects of the economic downturn. Exxon Mobil produces 
2.5M barrels of oil daily, or 3% of the world‘s total. Continued heavy project spending may 
allow combined oil and natural gas output to inch ahead in the coming years. Assuming global 
petroleum product demand rises, and lifts realized prices, earnings and the share price should 
regain lost ground in the coming years. 
 
Exxon‘s real strength is its productivity. Corporate projects are accomplished with a level of 
efficiency that lands Exxon among the industry‘s most profitable. Simply put, a company this big 
can always find ways do things better, given a well-trained and motivated workforce. Moreover, 
dedication to a business model that tightly weaves the oil producing, refining, and chemicals 
lines together has paid off handsomely, and we expect this trend to continue over the next year.  
We recommend holding Exxon over the next year and believe this position will pay off 
handsomely. 
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Chevron Corp – DECREASE POSITION 
Stock Symbol: CVX Market Capitalization: 149.48B 
Last Trade: 80.58 P/E (ttm): 15.38 
52 Week Range: 60.88 – 81.09 EPS (ttm): 5.24 
Dividend Yield: 3.70% Z-Score: 2.82 
Beta: 0.64 Revenue From Abroad: 86.2% 
Recommended Holding Period: Long-term 
 
Chevron Corporation operates as an integrated energy company worldwide. The company‘s 
Petroleum operations include the exploration, development, production, and marketing of crude 
oil and natural gas; refining, marketing, and transportation operations comprise refining crude oil 
into finished petroleum products; marketing crude oil and products derived from petroleum; and 
transporting crude oil, natural gas, and petroleum products by pipeline, marine vessel, motor 
equipment, and rail car. Its chemical operations include manufacture and marketing of 
commodity petrochemicals, plastics for industrial uses, and fuel and lubricant oil additives. The 
company also engages in the production and marketing of coal and molybdenum; development 
and operation of commercial power projects; and cash management and debt financing, 
corporate administrative, insurance, and real estate activities. Chevron Corporation was founded 
in 1879 and is based in San Ramon, California. 
 
Over the last year, Chevron has done very well, and is currently trading near its 52 week high.  
We expect oil prices to rise over the next year, causing revenues to be higher for Chevron; 
additionally, as Chevron moves closer to alternative fuels we can expect the long term profits of 
Chevron to rise. Chevron is a strong company and we expect Chevron to perform well over the 
next year.  Under normal circumstances we would hold Chevron; however, in order to be market 
neutral and considering Chevron is trading near its 52 week high, we recommend selling 170 
shares.   
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Clean Energy Fuels Corp. – DECREASE POSITION 
Stock Symbol: CLNE Market Capitalization: 1.28B 
Last Trade: 20.76 P/E (ttm): N/A 
52 Week Range: 5.89 – 23.02 EPS (ttm): -0.60 
Dividend Yield: N/A Z-Score: 9.96 
Beta: N/A Revenue From Abroad: 3% 
Recommended Holding Period: Long-term 
 
Clean Energy Fuels Corp. provides natural gas as an alternative fuel for vehicle fleets in the 
United States and Canada. It designs, builds, finances, and operates fueling stations and supplies 
compressed natural gas and liquefied natural gas. The company serves approximately 275 fleet 
customers operating 14,000 natural gas vehicles in public transit, refuse hauling, airports, taxis, 
seaports, and regional trucking markets. As of December 31, 2007, Clean Energy Fuels Corp. 
owned and operated 170 natural gas fueling stations in Arizona, California, Colorado, Maryland, 
Massachusetts, Nevada, New Mexico, New York, Texas, Washington, Georgia, Wyoming, and 
Canada. The company was incorporated in 2001 and is based in Seal Beach, California. 
 
Clean Energy Fuels Corp. as preformed well over the last year.  Unfortunately, to meet market 
weighting requirements we are forced to sell 250 shares. However, we believe that we are 
adequately compensating the portfolio for the time it held Clean Energy Fuels Corp., and believe 
that now would be the ideal time to sell these 250 shares as Clean Energy Fuels Corp. is selling 
well above cost basis.
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Suncor Energy, Inc. – HOLD 
Stock Symbol: SU Market Capitalization: 46.79B 
Last Trade: 35.09 P/E (ttm): 32.50 
52 Week Range: 22.77 – 39.62 EPS (ttm): 0.944 
Dividend Yield: 1.30% Z-Score: 1.25 
Beta: 1.65 Revenue From Abroad: 83.5% 
Recommended Holding Period: Long-term 
 
Suncor Energy, Inc., together with its subsidiaries, operates as an integrated energy company in 
Canada. It operates through four segments: Oil Sands, Natural Gas, Energy Marketing and 
Refining, and Refining and Marketing. The Oil Sands segment recovers bitumen, primarily 
through oil sands mining and in-situ development, and upgrades it into refinery feedstock, diesel 
fuel, and by-products. This segment offers light sweet crude oil/diesel and light sour crude 
oil/bitumen. The Natural Gas segment explores, acquires, develops, and produces natural gas and 
natural gas liquids from reserves in western Alberta and northeastern British Columbia. This 
segment also acquires land and explores for coal bed methane in the United States. The Energy 
Marketing and Refining segment refines crude oil into a range of petroleum, petrochemical, and 
bio-fuel products. It offers gasoline, diesel, jet fuels, petrochemicals, heating fuels, and heavy 
fuel oils for industrial, wholesale, commercial, and retail customers principally in Ontario and 
Quebec. This segment also engages in third party energy marketing and trading activities. The 
Refining and Marketing segment refines and markets jet fuels, diesel, gasoline, and asphalt. This 
segment also transports crude oil through wholly or partly owned pipelines in Wyoming and 
Colorado. In addition, the company carry on energy trading activities focused principally on 
buying and selling futures contracts and other derivative instruments based on the commodities it 
produce. Suncor Energy sells its products in the United States, Canada, and Europe. The 
company was founded in 1953 and is headquartered in Calgary, Canada.  Over the long term, 
Suncor is expected to be a strong investment.   
 
Cost basis is a limitation for recommending anything other than holding.  Currently Suncor is not 
a great buy, and we recommend holding until the market improves.
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 First Solar, Inc. – SELL 
Stock Symbol: FSLR Market Capitalization: 9.93B 
Last Trade: 132.60 P/E (ttm): 17.62 
52 Week Range: 98.71 – 207.51 EPS (ttm): 7.53 
Dividend Yield: N/A Z-Score: 10.44 
Beta: 1.52 Revenue From Abroad: 93.4% 
Recommended Holding Period: SELL 
 
First Solar, Inc. engages in the design, manufacture, and sale of solar electric power modules 
using a proprietary thin film semiconductor technology. The company‘s solar modules employ a 
thin layer of cadmium telluride semiconductor material to convert sunlight into electricity. It 
sells its products to project developers, system integrators, and operators of renewable energy 
projects in the United States and Europe. First Solar also focuses on designing and deploying 
commercial solar projects for utilities in the United States. First Solar was founded in 1999 and 
is headquartered in Tempe, Arizona.  
 
First Solar is attempting to penetrate the domestic market, via a relationship with SolarCity, a 
closely held firm that provides solar power capabilities to communities in California, Oregon, 
and Arizona. First Solar will provide 100 megawatts of modules, as well as a $25M equity 
investment, to SolarCity. The company has also begun installing small photovoltaic power plants 
on rooftops of commercial buildings in southern California. This is part of a plan by Southern 
California Edison (SCE) to install 250 megawatts of modules on building rooftops.  
 
First Solar has taken a beating over the last year, much of this is due to fears that the subsidies 
that have grown solar energy will be cut—mostly in Germany.  We do not think First Solar is a 
strategic hold over the next year, and we recommend selling all 50 shares.  First Solar has 
recovered over the last few months and we can almost cover our cost basis, allowing us to move 
closer to a market weighted portfolio. 
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Summary of Portfolio Allocation Changes 
 
Holding No. of 
Shares As of 
4/12/10 
Proposed 
No. of 
Shares  
Mkt Value 
As of 4/12/10 
Proposed 
Mkt Value  
CVX 275 155 $22,159      $9,652 
CLNE 500 370 $10,385   $2,523 
FSLR 50 0 $6,630 $0 
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If We Could Turn Back the Clock  
 
A neutral weight of the industrial sector is appropriate due to the remaining uncertainty in the 
economy and the possibility that recent price movements have taken into account a full recovery. 
 
Surprising growth in 2009   
                                                  
                      (Oct 2007 – Feb 2009)                                                           (Mar 2009 – Feb 2010) 
 
These charts show while the industrial sector mirrored the S&P 500 during the fall, it outpaced it 
during the 2009 recovery. The industrial sector's relies heavily on debt which leverages up the 
business model. In hindsight the industrial sector would have been a great investment in March 
2009, but we question whether this performance can continue into the future. 
 
Global Growth Story 
Because the industrial sector has taken advantage of revenue streams from abroad, we believe 
the tepid US recovery we are forecasting will have a smaller impact then one would normally 
expect. The IMF has recently forecasted 2010 world GDP growth of 3.9% compared to just 2.1% 
for the developed economies.  China and India lead the IMF 2010 GDP forecasts with 10% and 
7.7% growth respectively. Within our portfolio, only two industrial sector positions have less 
than 45% of their revenue coming from abroad and multiple companies have over 60% of their 
revenue from abroad. Based on the forecasted GDP growth, these diversified revenue streams 
should help insulate the sector and offer potential growth in the future. 
 
Proposed changes to the portfolio – Neutral Weight 
Under normal circumstances, we would recommend an underweight of the industrial sector 
based on the recent price movement and uncertainty in the economy, but their global positioning 
offers a level of diversification and growth that justifies a neutral weight in the portfolio.  
 
To help offset the potential downside risk and volatility still present in the economy, an emphasis 
should be placed on strong balance sheets and low valuations. In the case of higher valuations, a 
fundamental growth catalyst should be present to allow for a smooth transition to a more 
sustainable level. The balance sheets of each company should have enough flexibility that a 
severe recession will not cripple the business and force difficult decisions. Finally, the business 
Industrials S&P 500 S&P 500 Industrials
Industrials 
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models should be checked to make sure they still represent the industrial sector without abnormal 
active risk that would inflate the Z-Score under adverse scenarios. 
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Detailed Company Overviews  
 
Caterpillar – SELL  
Stock Symbol: CAT Market Capitalization: 36.39B 
Last Trade: 66.73 P/E (ttm): 41.92 
52 Week Range: 27.05 – 64.42 EPS (ttm): 1.43 
Dividend Yield: 2.52% Z-Score: 1.704 
Beta: 1.81 Revenue From Abroad: 66% 
Recommended Holding Period: Long-term 
 
We are recommending a complete liquidation of the Caterpillar position because we believe the 
current pricing of the company leaves little opportunity to the upside and more risk to the 
downside. 
 
Caterpillar was founded in 1935 and has became the largest manufacturer of construction and 
mining equipment, diesel and natural gas engines, and industrial gas turbines according to their 
website. They serve three primary business lines including machinery, engines, and financial 
products with machinery the largest portion at 60% of revenues. Caterpillar is the essence of a 
global company with a significant portion of their revenue and staff present in other parts of the 
world. 
 
Caterpillar‘s stock has shown a strong appreciation over the past ten months moving from a low 
of $22 per share to the current position of $60.36.  While the stock‘s price action can be 
somewhat justified by a 1.81 beta, I believe this move has priced in a majority of the available 
upside. 
 
Caterpillar is currently pricing at a PE ratio of 42 which will require a significant increase in 
their earnings per share to justify the current price levels. Ultimately, even if the economy does 
fully recovery we can find better opportunities in the industrial sector that will offer better risk-
adjusted returns with the addition of some downside protection through more favorable 
valuations. 
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General Electric – SELL  
 
We are recommending a full liquidation of the General Electric position because the stock no 
longer correlates with the industrial sector in a difficult economy. 
 
General Electric, a heavy-equipment, media and financing giant does business through five 
segments: Energy Infrastructure, Technology Infrastructure, NBC Universal, Capital Finance, 
and Consumer & Industrial. 
 
During the past few years, General Electric has seen its stock price go from a high of almost $42 
per share down to a low of roughly $6 per share. The most important question one should ask is 
why did this fall take place? The one constant answer to this question is their capital finance 
division which faced extreme de-valuations of their investments.  
 
While General Electric may have survived the fallout, its stock was treated like a pseudo 
financial company.  If the economy is faced with a second crisis, we believe its stock price will 
once again correlate with the financial sector compared to its fundamental positioning as an 
industrial. This leads us to recommend selling this holding. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stock Symbol: GE Market Capitalization: 172.31B 
Last Trade: 18.71 P/E (ttm): 19.2 
52 Week Range: 10.5 – 19.4 EPS (ttm): 1.01 
Dividend Yield: 2.14% Z-Score:  N/A 
Beta: 1.55 Revenue From Abroad: 50% 
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Jacobs Engineering Group – INCREASE POSITION 
Stock Symbol: JEC Market Capitalization: 4.90B 
Last Trade: 46.74 P/E (ttm): 16.79 
52 Week Range: 33.70 – 49.73 EPS (ttm): 2.85 
Dividend Yield: N/A Z-Score:  5.930 
Beta: 1.35 Revenue From Abroad: 36% 
Recommended Holding Period: Long-term 
 
We are recommending an increase to this position due to Jacobs Engineering Group‘s low 
valuation and strong balance sheet. 
 
Jacobs Engineering focuses on providing a broad range of technical, professional and 
construction services to a large number of industrial, commercial and governmental clients 
worldwide. Jacobs Engineering‘s two primary philosophies related to its business model are 
multi-domestic and boundary-less approach. Multi-domestic includes locally staffed offices that 
share the corporate view and boundary-less is related to global services.  
 
Jacobs Engineering‘s price has been relatively stable compared to most other companies over the 
last year, but they experienced their large swing right before the masses. Jacob‘s stock price fell 
from a high of $96 dollars in May 2008 to a low of $26 dollars in Nov 2008.  The stock price has 
since found stability in the $40 dollar range, and has mostly ignored the bull market from March 
of 2009 to current.  
 
While a majority of Jacobs‘ revenue may come from the domestic market, they are involved in 
specific businesses that allow for growth. Their energy business has been growing at 25% per 
year, and now represents approximately 33% of their total revenue line.  They have also been a 
winner in the national government spending plans which includes environmental and aerospace 
programs. These spending plans have increased a little over 100% the past five years and now 
represent almost 16% of their revenue. Finally, Jacobs‘ current ratio is over 2 and they have 
almost no long-term debt.  
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Chicago Bridge & Iron Co. N.V– HOLD 
 
We are recommending to hold our position in CBI due to their low valuation and large backlog 
of business which should offer some protection from short-term weakness.  
 
Chicago Bridge & Iron Co. N.V. is a global, engineering, procurement and construction 
company specializing in turnkey projects for customers that produce, process, store and 
distribute the world's natural resources. Chicago Bridge & Iron Company focuses on energy 
infrastructure projects for oil and gas companies. CBI has approximately 16,000 employees and 
works on over 600 projects a year according to their latest quarterly report. 
 
Chicago Bridge & Iron Co. has had an extremely volatile year reaching a low in the $4 range and 
since increasing almost 400% to $22 dollars.  Under normal circumstances this kind of move 
would be an enormous red flag, but CBI is still trading at a relatively low PE of 12.92 and 
significantly off an all time high in the lower $50s reached in early 2008. 
 
CBI has almost 1.5 years worth of revenue covered in current backlog, and is forecasting to 
again grow their backlog this year. One negative aspect is their 2010 personal forecast of only 
$3.9-$4.2 billion in revenue which is down roughly $1 billion from the full year 2009, but this 
estimate was made public and should be priced into the stock. Cost reductions have softened the 
blow to net income, and the forecasted EPS range is still from 1.60 – 1.80 compared to $1.79 in 
2009.  Analyst expectations for 2011 show CBI returning to previous revenue levels and net 
income over $2.00 a share. Their current PE should allow for some latitude in pricing, and based 
on 2011 expectations there is room to the upside.  
 
 
 
 
 
 
 
 
 
 
Stock Symbol: CBI Market Capitalization: 2.20B 
Last Trade: 24.00 P/E (ttm): 13.74 
52 Week Range: 7.35 – 25.00 EPS (ttm): 1.79 
Dividend Yield: N/A Z-Score: 2.046 
Beta: 2.51 Revenue From Abroad: 65% 
Recommended Holding Period: Long-term 
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Danaher Corp – HOLD 
 
We are recommending to hold our position in Danaher Corp because it is a lower beta name that 
has significant exposure to the medical industry and potential for strong growth in their water 
treatment division.  
 
Danaher Corp. is a leading maker of hand tools and process and environmental controls. The 
company has four reporting segments: professional instrumentation, industrial technologies, 
tools, and medical technologies 
 
A major portion of Danaher‘s revenue comes from the medical industry which should be more 
resilient to a potential downturn in the economy. We believe this will fit in well with our 
portfolio where many of the other industrial companies have betas closer to 1.5. Along with the 
medical industry, Danaher is also the leader in water treatment. The population growth present in 
many countries abroad is leading to a general shortage of food and water, so water treatment will 
be a growing industry in the future. According to the United Nations Intergovernmental Panel on 
Climate Change ―By 2025 it is estimated that 1.8 billion people will be living in conditions of 
absolute water scarcity and two-thirds of the world‘s population could be living under water-
stressed conditions.‖ 
 
Danaher‘s current PE makes it a somewhat expensive stock to own, but analysts‘ earnings 
expectations will have the PE ratio coming back in line over the next two years. We believe the 
combination Danaher‘s diversified revenue streams and low beta make them an ideal stock to 
pair with many of our other industrial positions. 
 
 
 
 
 
 
 
 
 
 
Stock Symbol: DHR Market Capitalization: 24.51B 
Last Trade: 80.36 P/E (ttm): 23.37 
52 Week Range: 52.80 – 80.36 EPS (ttm): 3.46 
Dividend Yield: .2% Z-Score:  3.523 
Beta: .85 Revenue From Abroad: 49% 
Recommended Holding Period: Long-term 
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HEICO Corp. - HOLD  
 
We are recommending a hold on the current position in HEICO due to their business model of 
specializing in spare parts. We believe the spare parts business allows us to take advantage of 
businesses and governments extending the life of their capital equipment. 
 
HEICO Corp. makes jet engine replacement parts and electronic equipment through two 
segments: the Flight Support Group and the Electronic Technologies Group.  HEICO Corp has 
approximately 2100 full time employees and reached fiscal 2009 sales of $538 million dollars. 
HEICO participated in a wide range of acquisitions in the mid 2000s, and management has 
alluded to the possibility of more. HEICO‘s stock price has been volatile over the past few years, 
but is currently trading near its all-time high of approximately $56.00 
 
At first glance, HEICO appears to be significantly overvalued with a PE of 30, but a deeper look 
shows a solid business model with growth potential. Any business involved with the airlines and 
government contracts has significant risk over the next few years due to the record debt levels 
held by governments, but HEICO focuses on the spare parts segment which should be less 
volatile then other areas as useful life is extended to reduce capital investments. They had $107 
million in backlog at the end of 2009 which is comparable to 2008, but much of their business is 
short-lead time. HEICO has always maintained a conservative stance on their balance sheet and 
this is visible with a current ratio close to 3.7 and limited amount of debt. Finally, at only 32% of 
revenue from abroad HEICO has a significant opportunity to grow their sales and margins as 
they receive additional orders from the international market.  
 
 
 
 
 
 
 
 
 
 
 
Stock Symbol: HEI Market Capitalization: 1.18B 
Last Trade: 51.01 P/E (ttm): 30.92 
52 Week Range: 26.32 – 52.86 EPS (ttm): 1.67 
Dividend Yield: .24% Z-Score:  4.036 
Beta: 1.22 Revenue From Abroad: 32% 
Recommended Holding Period: Long-term 
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3M - HOLD  
 
We are recommending a hold in our position of 3M stock because of its diversified revenue 
streams and low beta. 
 
3M reports its business in six segments: Industrial and Transportation, Health Care, Display and 
Graphics, Consumer and Office, Electro and Communications, and Safety, Security and 
Protection Services. 
 
3M like many other companies tightened their belt in 2009 by reducing capital expenditures by 
38% and offering no merit raises, but they still maintained their high R&D budget and expanded 
in select locations.  3M already has approximately 63% of their revenue coming in from abroad, 
but in 2009 they still accelerated their expansion into China and India. Along with having a 
diversified revenue stream by geographic location, they also have many successful business units 
with the highest generating only 30% of their revenue.  
 
3M status as a conglomerate helps it achieve a low beta of .79 which we believe fits well in our 
industrial portfolio. They pay a dividend yield of 2.6%, and their financial health looks sound. 
Analyst‘s earnings estimates over the next two years bring their PE ratio down to a more 
sustainable level around 15.  We believe this is a lower risk stock that will be a good 
complement in our portfolio. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stock Symbol: MMM Market Capitalization: 57.93B 
Last Trade: 83.28 P/E (ttm): 18.68 
52 Week Range: 51.63 – 85.17 EPS (ttm): 4.52 
Dividend Yield: 2.52% Z-Score:  N/A 
Beta: .79 Revenue From Abroad: 63% 
Recommended Holding Period: Long-term 
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United Technologies – HOLD 
 
We are recommending that we hold our position in UTX due to their increased dividend yield 
and fair valuations. United Technologies‘ broad business model hits on many areas in the 
industrial sector and with a backlog capable of supporting sales for at least one year there is time 
to weather an adverse economy. 
 
United Technologies is a multi-industry holding company that conducts business through six 
business segments: Carrier (HVAC), Otis (Elevators), Pratt & Whitney (Jet Engine supplier), 
UTC Fire & Security, Hamilton Sundstrand (Aerospace Supplier), and Sikorsky (Helicopters).  
These business segments are well diversified with Carrier representing the largest portion of 
revenue at roughly 15% of the business. 
 
United Technologies‘ is currently trading at the top of its 52 week range after a volatile previous 
year. Their PE ratio shows a relatively fair valuation, but this should improve as earnings grow 
over the next two years according to analyst expectations. While their backlog has fallen roughly 
7 billion dollars over the previous year, they still have approximately 52 billion in orders on hand 
which ties closely to a year worth of sales. This backlog will help UTX navigate the current 
economy better than most companies which have much shorter visibility in their future sales and 
orders. Their balance sheet has stayed relatively stable over the past few years with a manageable 
level of debt on the books. Along with strong financials, they have recently increased their 
dividend yield to 2.4%. 
 
 
 
 
 
 
 
 
 
 
 
Stock Symbol: UTX Market Capitalization: 64.32B 
Last Trade: 73.76 P/E (ttm): 17.95 
52 Week Range: 45.31 – 73.76 EPS (ttm): 4.12 
Dividend Yield: 2.3% Z-Score:  3.138 
Beta: 0.97 Revenue From Abroad: 52% 
Recommended Holding Period: Long-term 
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Summary of Portfolio Allocation Changes 
 
Holding No. of 
Shares As of 
4/12/10 
Proposed 
No. of 
Shares  
Mkt Value 
As of 4/12/10 
Proposed 
Mkt Value  
CAT 50 0 $2,842  $0  
GE 150 0 $2,403  $0  
CBI 100 250 $2,224  $5,837  
FLS 0 100 $0  $10,485  
JEC 200 300 $7,980  $13,020  
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A Growing Sector  
 
Currently, the SunTrust Portfolio‘s overweight in the materials sector. Over the last several 
years, the materials sector has been greatly impacted by the global economic recession.  
Subsectors such as raw materials, chemical manufacturing, and metal and mining have been 
negatively affected, and the slowdown caused a substantial drop in demand for raw materials. 
However, we expect this to change, The Total Construction-Related Spending from Obama‘s 
131 Billion dollar stimulus plan shows that over 60Billion (49.3%) will be spent on 
transportation, this will drive a market for raw materials, and ultimately increase the value of the 
materials sector.
1
  Additionally, chemical manufacturers involved in fertilizer and agricultural 
chemical manufacturing have experienced significant losses due to falling agricultural 
commodity prices. However, it appears that this trend is changing, we believe with a move 
towards sustainable farming and conservation commodity prices will recover.  To guard against 
further losses, and capitalize on positive changes in the market, we recommend market weighting 
the materials sector. 
 
 
 
 
 
Detailed Company Overviews 
Materials 
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Companhia Vale Do Rio Doce – HOLD 
Stock Symbol: VALE S.A. Market Capitalization: N/A 
Last Trade: 26.64 P/E (ttm): N/A 
52 Week Range: 26.37 – 26.82 EPS (ttm): N/A 
Dividend Yield: N/A Z-Score:  
Beta: N/A Revenue From Abroad: 98% 
Recommended Holding Period: Long-term 
 
Companhia Vale do Rio Doce (Vale) is a Brazil-based company engaged in the metal and 
mining industries. The Company provides components for such products as appliances, 
electronic equipment, cars, computers and construction materials, among others. The Company 
is also active in the exploration of iron ore, nickel, aluminum, copper, coal, cobalt, precious 
metals, potassium and other minerals. Vale operates logistic systems in Brazil, including 
railroads and maritime terminals, which are related to the mining operations. The Company‘s 
main subsidiaries are Brasilux SA, Companhia Paulista de Ferro Ligas, CVRD Overseas Ltd and 
Docepar SA, among others. In March 2009, the Company sold its stake in Usinas Siderurgicas de 
Minas Gerais S.A.
35
 In 2008, the Olympic Games were hosted by China.  China spent over $43 
billion and the better part of a decade preparing for the Beijing Olympics. As Brazil will be 
hosting the 2016 Olympics, we expect Brazil will invest several billion dollars in 
infrastructure—increasing the demand of raw materials, and producing the perfect storm for 
Brazil‘s economic development and Companhia Vale Do Rio Doce‘s growth.  We recommend 
holding Vale, and believe it will perform well in the years to come. 
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Dow Chemical Company – HOLD 
Stock Symbol: DOW Market Capitalization: 34.5B 
Last Trade: 31.20 P/E (ttm): 97.81 
52 Week Range: 10.50 – 31.66 EPS (ttm): 0.32 
Dividend Yield: 2.00% Z-Score: 1.41 
Beta: 2.28 Revenue From Abroad: 69% 
Recommended Holding Period: Long-term 
 
The Dow Chemical Company engages in the manufacture and sale of chemicals, plastic 
materials, agricultural, and other specialized products and services worldwide. The company 
operates in six segments: Performance Plastics, Performance Chemicals, Agricultural Sciences, 
Basic Plastics, Basic Chemicals, and Hydrocarbons and Energy. The Performance Plastics 
segment provides automotive products, building solutions, epoxy resins, intermediates and 
specialty resins, polyurethanes and polyurethane systems, specialty plastics and elastomers, and 
technology licensing and catalyst products. The Performance Chemicals segment offers 
polymers, latex, and specialty chemicals. The Agricultural Sciences segment provides pest 
management, agricultural, and crop biotechnology products and solutions. The Basic Plastics 
segment offers polyethylene, polypropylene, and polystyrene resins. The Basic Chemicals 
segment provides chemicals, such as acids, alcohols, caustic soda, chlorine, chloroform, and 
other chemicals; and ethylene oxide/ethylene glycol chemicals. The Hydrocarbons and Energy 
segment procures fuels, natural gas liquids, and crude oil-based raw materials, as well as supplies 
monomers, power, and steam. Its products include benzene; butadiene; butylene; cumene; 
ethylene; propylene; styrene; power, steam, and other utilities. The company also involves in the 
property and casualty insurance and reinsurance business through its Liana Limited subsidiaries. 
It serves various industries, including appliance; automotive; agricultural; building and 
construction; chemical processing; electronics; furniture; house wares; oil and gas; packaging; 
paints, coatings, and adhesives; personal care; pharmaceutical; processed foods; pulp and paper; 
textile and carpet; utilities; and water treatment industries. The Dow Chemical Company was 
founded in 1897 and is based in Midland, Michigan.
36
  
 
Over the last year Dow has made strides to reconnect with their founding principles and return to 
a business model that will return them to the chemical industries‘ leader.  Over the last year, 
Dow has increased its share value by over 300%.  In the coming year we expect Dow to continue 
to grow in value, and recommend holding. 
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Helmerich & Payne, Inc. – INCREASE POSITION 
Stock Symbol: HP Market Capitalization: 3.86B 
Last Trade: 39.95 P/E (ttm): 15.72 
52 Week Range: 21.76 – 49.13 EPS (ttm): 2.54 
Dividend Yield: 0.50% Z-Score: 2.73 
Beta: 1.04 Revenue From Abroad: 68% 
Recommended Holding Period: Long-term 
 
Helmerich & Payne, Inc. engages in the contract drilling of oil and gas wells in the United States 
and internationally. The company provides drilling rigs, equipment, personnel, and camps on a 
contract basis to explore for and develop oil and gas from onshore areas and from fixed 
platforms, tension-leg platforms, and spars in offshore areas. It conducts domestic land drilling 
primarily in Oklahoma, California, Texas, Wyoming, Colorado, Louisiana, Mississippi, 
Alabama, Utah, Arkansas, New Mexico, and North Dakota, and offshore drilling from platforms 
in the Gulf of Mexico, California, Trinidad, and Equatorial Guinea. As of September 30, 2008, 
the company had 185 land drilling rigs in the United States; 8 offshore platform rigs; and 
international land rigs, including 11 in Venezuela, 4 in Ecuador, 5 in Argentina, 5 in Colombia, 
and 1 in Tunisia. In addition, Helmerich & Payne engages in the ownership, development, and 
operation of real estate, principally commercial properties, in Tulsa, Oklahoma. Its property 
portfolio includes a shopping center and a multi-tenant warehouse space. The company was 
founded in 1920 and is based in Tulsa, Oklahoma.
37
  
 
On February 26, 2010, Helmerich & Payne joined the S&P500 index this is a clear indication of 
the market‘s faith in Helmerich‘s management and long-term growth opportunities. Over the 
next 12 months, we expect Helmerich & Payne to capitalize on the increased demands in oil and 
profits to increase.  We recommend purchasing an additional 20 shares.  
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Monsanto Company – INCREASE POSITION 
Stock Symbol: MON Market Capitalization: 38.80B 
Last Trade: 65.73 P/E (ttm): 27.39 
52 Week Range: 66.57 – 93.35 EPS (ttm): 2.40 
Dividend Yield: 1.50% Z-Score: 4.73 
Beta: 0.71 Revenue From Abroad: 46% 
Recommended Holding Period: Long-term 
 
Monsanto Company provides agricultural products for farmers in the United States and 
internationally. It operates in two segments, Seeds and Genomics, and Agricultural Productivity. 
The Seeds and Genomics segment produces corn, soybeans, canola, and cotton seeds, as well as 
vegetable and fruit seeds, including tomato, pepper, eggplant, melon, cucumber, pumpkin, 
squash, beans, broccoli, onions, and lettuce. This segment also develops biotechnology traits that 
assist farmers in controlling insects and weeds, as well as provide genetic material and 
biotechnology traits to other seed companies for their seed brands. The Agricultural Productivity 
segment offers glyphosate-based herbicides for agricultural, industrial, ornamental, and turf 
applications; lawn-and-garden herbicides for residential lawn-and-garden applications; and other 
selective herbicides for control of preemergent annual grass and small seeded broadleaf weeds in 
corn and other crops. The company offers its products under various brands, including the 
Roundup Ready, Bollgard, Bollgard II, YieldGard, YieldGard VT, Roundup Ready 2 Yield, and 
SmartStax for traits; DEKALB, Asgrow, Deltapine, and Vistive for row crop seeds; Seminis, De 
Ruiter, Royal Sluis, Asgrow, and Petoseed for vegetable seeds; Roundup for herbicides; and 
Harness for corn. It also licenses germplasm and trait technologies to seed companies. The 
company sells its products through distributors, retailers, dealers, agricultural co-operatives, 
plant raisers, and agents, as well as directly to farmers. Monsanto Company has a joint venture 
with Cargill, Inc. to commercialize a proprietary grain processing technology under the name 
Extrax. It has collaborations with BASF in plant biotechnology that focuses on high-yielding 
crops and crops that are tolerant to adverse conditions; and Biotechnology, Inc. to source genetic 
elements that enable crops to express desirable traits. The company, in its current form, was 
established in 2000 and is based in St. Louis, Missouri.
38
 
 
Monsanto is growing rapidly, increasing its base of genetically engineered crops and its 
expanding IP portfolio is expected to add tremendous value to their valuation.  Over the next 
year, we expect the Monsanto to grow and profits to increase.  We recommend purchasing an 
additional 17 shares. 
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Summary of Portfolio Allocations 
 
Holding No. of 
Shares As of 
4/12/10 
Proposed 
No. of 
Shares  
Mkt Value 
As of 4/12/10 
Proposed 
Mkt Value   
HP 100 20 $3,995 $4,794 
MON 75 17 $4929 $6,047 
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Why Bother?39  
 
The Telecommunications sector as a whole is fairly priced but there are opportunities to explore, 
especially in the communication infrastructure sub industry due to the increasing trend of data 
hungry consumers. Due to the existing high penetration, current conditions, and the uncertainty 
of the future, the outlook on the telecommunication sector is neutral. Our view on the 
telecommunication sector is market weight to underweight. 
 
The Status Quo 
The telecommunications industry is divided into two main industries: wireline and wireless 
industries. Virtually the same companies that compete in the wireline industry compete in the 
wireless industries as well.  Regulations, innovations, and consolidations have hurt the wireline 
segment as customers are making the move to the wireless industry. 
 
The Wireless industry, which is dominated on the services side by AT&T and Verizon, has 
enjoyed high penetration rate in the US. While the industry will grow, it will be a declining rate 
because of the high penetration it has already achieved, high unemployment rate, and sluggish 
economic recovery. With the depth of the just concluded recession, the timeline of recovery, and 
unemployment rate of about 9.7%, the outlook for the telecommunications industry is neutral.  
 
Historically, the weight of the telecommunications sector within the S&P 500 allocations was 
never sizeable. At the height of the Tech bubble, the weight was a paltry 5.5%. As it is not a 
domineering sector, should we even bother digging deep into the sector? 
 
A Silver Lining 
High growth areas in the industry are the prepaid and wireless data segments. The rise of data 
hungry users is a sustainable trend that presents an opportunity for investments. 
With the explosion of wireless data segment, network upgrades will be needed to support data 
hungry users. As the economy recovers, this segment will experience explosive growth. The rise 
of data hungry customers will benefit companies that provide communication infrastructure like 
cell tower providers especially with the ongoing momentum of 4G and WiMax technologies. 
 
Proposed Changes in Telecommunications sector 
From our findings and consensus outlook, the telecommunications sector weight should be range 
from under weighted to market neutral. Investments should be made in cell tower providers and 
major service carriers as they are best positioned to increase profitability by a substantial 
amount.  
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Detailed Company Overviews  
 
iShares S&P Global Telecommunications
40
 – DECREASE POSITION 
Stock Symbol: iXP Market Capitalization: 261.25M 
Last Trade: 52.57 P/E (ttm): N/A 
52 Week Range: 42.77 – 57.44 EPS (ttm): N/A 
Yield: 4.35% Z-Score: NA 
Beta: 0.83 Revenue From Abroad: 68% 
Recommended Holding Period: Long-term 
 
The iShares S&P Global Telecommunications Sector Index Fund seeks investment results 
that correspond generally to the price and yield performance, before fees and expenses, of 
companies that Standard & Poor's deems part of the telecommunications sector of the 
economy and important to global markets, as represented by the Standard & Poor's Global 
Telecommunications Sector Index.
41
 
 
Due to the low weight of the sector and the defensive investment approach, a fund represents the 
best method to capture the essence of the sector and diversify the investment, thereby reducing 
overall risk. 
 
The iXP fund meets the all the aforementioned criteria and is representative of the major 
telecommunications service providers in the US and abroad. About 31% of its holdings are in 
U.S. securities, and the five countries it invests in most heavily comprised only 64% of its 
holdings as of March 09, 2010. With this diversification also comes heavy investment in large, 
relatively stable companies. The Morningstar risk and return rating for the iXP fund is low and 
above average respectively. 
 
Because a number of funds could meet the above criteria, the iXP fund was compared to a 
number of other funds to determine the best investment.  In terms of the risk-return relationship, 
the iXP fund is head and shoulders above all other comparable funds.  
 
Furthermore, the iXP fund has the highest yield out of all the funds and the lowest turnover rate. 
In terms of expenses, it is not the most attractive but it is quite competitive. In light of these 
criteria and the industry outlook, the iXP fund proved the most attractive investment. 
 
Since iXP is the only asset in the Telecommunications sector, some of the shares have to be sold 
to buy additional assets for this sector. 
                                                 
40
 All information compiled from Morningstar, Yahoo! Finance, FinViz, and NetAdvantage 
41
 Fund description at http://us.ishares.com. 
 57 
American Tower Corporation
42
 – BUY 
Stock Symbol: AMT Market Capitalization: 16.77B 
Last Trade: 41.65 P/E (ttm): 69.61 
52 Week Range: 27.93 – 45.00 EPS (ttm): 0.61 
Dividend Yield: 0% Z-Score: 1.350 
Beta: 0.90 Revenue From Abroad: 18% 
Recommended Holding Period: Long-term 
American Tower Corporation is the market leader in Cell Tower infrastructure ahead of Crown 
Castle Inc and SBA communications. It operates about 26000 towers in the US, Mexico, India 
and Brazil. AMT‘s customers include Verizon, AT&T, Sprint Nextel, T-Mobile USA, etc. 
 
Like its peers, AMT enjoys long-term contracts with major service providers driving recurring 
revenue and minimal ongoing capital once the tower is built delivering much of the revenue to 
the bottom line. The explosion of the wireless data segments means that the service providers 
need to expand their networks and turning to a well established company like AMT is a forgone 
conclusion. We expect the tenants (major service providers) per tower to show upward trend. 
AMT stands to gain from this growth as it has spare capacity on its towers 
 
AMT‘s exposure and continued presence in Latin America and India is an added benefit as those 
regions are poised for tremendous growth and that would lead to increased revenue streams. 
However, about 82% of AMT‘s revenue is from the US. AMT recently announced plans to 
acquire additional towers in India doubling its presence and increasing visibility in India and in 
emerging markets. Presently AMT‘s penetration in Mexico, Brazil, and India are 67%, 70%, and 
25%. 
 
Of all the companies in the industry, AMT has the longest contract reducing the volatility of 
incoming revenue. It has secured long term contracts which escalate in price by 3% to 5% per 
year. AMT‘s 41% operating margin easily outpaces its competitors and its focus on operating 
efficiency has helped AMT stand above other competitors in the sector. In addition, AMT has 
the lowest leverage at 4.4 times operating income, meaning a sizeable portion of the revenue will 
be transferred to the bottom line. 
 
AMT will is expected to experience revenue growth of about 8% annually through 2013. The 
trend of data hungry users will continue to ensure the need for cell towers which reduces 
uncertainty concerning AMT‘s future. All in all, AMT‘s enviable position, guaranteed recurring 
revenue and its expansion into emerging markets makes it an attractive investment considering 
the sluggish economic growth in the US. 
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 All information compiled from Morningstar, Yahoo! Finance, FinViz, and NetAdvantage 
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Crown Castle Inc
43
 – BUY 
Stock Symbol: CCI Market Capitalization: 10.85B 
Last Trade: 37.04 P/E (ttm): N/A 
52 Week Range: 19.96 – 40.49 EPS (ttm): -0.47 
Dividend Yield: N/A Z-Score: NA 
Beta: 1.64 Revenue From Abroad: 5% 
Recommended Holding Period: Long-term 
Crown Castle Inc is the largest independent operator of wireless tower communications in the 
United States. CCI owns about 22,000 tower sites in the US and about 1,600 in Australia. Some 
of its largest customers include Verizon, AT&T, Sprint Nextel, T-Mobile, etc. 
 
Like its peers, CCI enjoys long term contracts with major service providers driving recurring 
revenue and minimal ongoing capital once the tower is built delivering much of the revenue to 
the bottom line. The explosion of the wireless data segments means that the service providers 
will continue to depend on companies like CCI to sustain data hungry users. We expect the 
tenants (major service providers) per tower to show upward trend. 
 
The reliability of CCI‘s revenue is a confidence booster for investors and it also makes it easier 
for the firm to obtain credit financing. CCI has more than 97% of the coming year projections 
already under contract. CCI also enjoys long term contracts with price escalators embedded into 
these long term contracts. 
 
CCI‘s strategy is to internally increase revenue and cash flows from towers by maximizing its 
tenant/tower ratio. Management is likely to buy back some shares to allocate capital efficiently, 
make timely acquisitions of land and towers and, construct additional towers. 
 
Through 2013, CCI is expected to experience 9.9% annual growth in revenue. The company‘s 
leverage has been steadily decreasing while its revenue has been increasing. Overall CCI‘s 
guaranteed revenues and its expansion potential to other countries make it a profitable 
investment. 
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 All information compiled from Morningstar, Yahoo! Finance, FinViz, and NetAdvantage 
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Summary of Portfolio Allocations 
 
Holding No. of 
Shares As of 
4/12/10 
Proposed 
No. of 
Shares  
Mkt Value 
As of 4/12/10 
Proposed 
Mkt Value   
iXP 250 100 $13,272 $5,440 
AMT 0 130 $0 $5,752 
CCI 0 103 $0 $3,842 
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A Sector Shrouded With Uncertainty  
 
In 2009, the utilities sector experienced downturns because of a plunge in industrial demand, 
fears concerning market cap and trade, and a potential increase in interest rates. However, we 
believe the utilities sector will experience moderate growth compared to 2009. 
 
Plunge in Industrial Demand 
The overall utilities sector was the worst performing sector in 2009. We expect, however, 
moderate growth because prices for natural gas have plunged more than 65% from their 2008 
highs.  Based on our prediction of slow economic growth in 2010, fundamental support from 
continued global economic recovery and additional support from stimulus spending, industrial 
demand will moderately increase. Additionally, the WSJ reports less price volatility as natural 
gas producers continue to tap new fields and secure low-cost supplies that will compete more 
effectively against coal—a staple fuel source for electricity generation currently used in the U.S.  
 
Uncertainty over Cap and Trade  
The looming threat of new legislation on emissions, similar to cap and trade regulation—
regulation that sets a government limit on overall emissions of pollutants and allows emitters to 
trade pollution permits among themselves—contributed to a plunge in industrial demand in 
2009. Less than a year ago, cap and trade was the policy of choice for tackling climate change, 
according to New York Times, and the authors of the House climate and energy bill passed last 
June largely built their measure around it.
44
 Currently, however, cap and trade is in wide 
disrepute. Teams of senators are in the process of writing new legislation on global warming, cap 
and trade, and emissions. The initial scare caused by the threat of new legislation helped drive 
down industrial demand in 2009. We believe, however, that market investors are beginning to 
regain their confidence, which will translate into moderate growth in the utilities sector in 2010.  
 
Increase in Interest Rates 
The utilities sector tends to have a large debt load, which makes it sensitive to changes in interest 
rates. To the point, utility securities usually perform best during a recession when interest rates 
are falling or are already low. Periods of high or increasing interest rates are never a good time to 
own utilities. Expected growth in the sector and the Fed‘s intention to keep interest rates low for 
an ―extended period‖ could provide a low-risk investment opportunity.   
 
 
 
Conclusion 
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 http://www.nytimes.com/2010/03/26/science/earth/26climate.html?src=me 
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We believe the sector‘s positives will more than withstand the headwinds. Contributors to sector 
headwinds include the possibility industrial demand will not recover and an expected increase in 
interest rates in 2010. We agree with the WSJ’s prediction that industrial demand will see a 
moderate increase in the next year; thus providing growth opportunities within the sector.45   
 
Proposed Changes in Utilities Portfolio 
 Maintain current holdings in VPU. 
 Purchase 130 additional shares of VPU at $64.32 per share. 
                                                 
45
 
http://online.wsj.com/article/SB10001424052748703909804575123382402515558.html?KEYWORDS=industrial+
demand 
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 Detailed Company Overviews  
 
Vanguard Utilities ETF – INCREASE POSITION 
Stock Symbol: VPU Market Capitalization: 464.18M 
Last Trade: 64.32 P/E (ttm):  12.7 
52 Week Range: 50.35 – 65.86 EPS (ttm): NA 
Dividend Yield: 3.87% Expenses: 0.25% 
Beta: 0.61 Revenue From Abroad: NA 
Recommended Holding Period: Long-term  
 
This investment tracks the performance of a benchmark index that tracks the MSCI U.S. 
Investable Market Utilities Index.  This ETF provides low-cost exposure to the utilities sector.
Summary of Portfolio Allocation Changes 
 
Holding No. of 
Shares As 
of 4/12/10 
Proposed 
No. of 
Shares  
Mkt Value 
As of 
4/12/10 
Proposed Mkt 
Value  
VPU 210 340 $13,232 $21,852 
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Will Financials Emerge From the Rubble?  
 
The threat of onerous new regulations, the end of the bailout, and an unenthusiastic residential 
and commercial real estate market makes a conservative market-neutral stance most prudent.  
 
Regulation 
Although the timing is uncertain, financial companies that emerge from the rumble left by the 
recent recession will face tighter regulation. Regardless of current proposals and recently 
adopted regulations, we believe governments will, in their attempts to stabilize the system, 
inhibit innovation and constrain profitability. Additionally, according to The Economist, tighter 
government regulation will cause financial companies to intensify their focus on managing—and 
avoiding—risk in the financial sector in 2010.46 If banks take less risk, can they earn more 
profits?  
 
The Bailout Must End 
In 2010 government bailout programs will be phased out, leaving banks with fragile balance-
sheets. Subsequently, interest rates will rise and banks will have to pay more for funding, putting 
additional pressure on profitability. The financial sector, however, has demonstrated moderate 
market growth in 2010, as big Western banks continue to stabilize, according to The 
Economist.
47
 While the future may be bleak for many small banks and other financial service 
companies, there are a few large firms with good management and solid fundamentals that merit 
attention. Financial Institutions that are in recovery have been able to raise capital, but they 
continue to prioritize their troubled assets.  
 
Real Estate 
Real Estate was hit hard by declining property values, defaulting tenants, reduced consumer 
spending, and the liquidity crisis in the recent recession; however, there are signs the panic that 
ensued a year ago is starting to lessen. For example, Reuters News reported U.S. foreclosure 
filings dropped off for the second straight month in February of this year.
48
 Furthermore, 
according to The Economist, the U.S. real estate market is almost back to being priced around 
fair value on the basis of rental yields.
49
  However, commercial property loans will roll over to 
tighter credit standards across the U.S., according to the Wall Street Journal. Tighter credit 
standards, could put added pressure on small and regional banks from losses on commercial real 
                                                 
46 A Better black-swan repellent. (2010, February 13).The Economist, 394(8664), 15-16. 
  47 Palmer, A. (2009, November 13). Ups and downs. The Economist, 393(8656), Retrieved from    
         http://www.economist.com/theworldin/displaystory.cfm?story_id=14742692&source=login_payBarrier 
48 Haviv, J. (2010, March 11). U.s. foreclosures drop 2nd straight month in February. Retrieved from  
       http://www.reuters.com/article/idUSN1017487820100311?type=marketsNews 
49 Bubble warning. (2010, January 7). The Economist,394(8664), 13. 
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estate loans, hindering their ability to lend to small businesses and hurting the broader 
economy.
50
  
 
Conclusion 
The outlook for the financial sector in 2010 is uncertain because of looming government 
regulations, the end of the bailout, and an unenthusiastic real estate market. Therefore, anything 
but a conservative stance would be unwise at this time. Despite our recommendation of a market 
neutral weighting, there are a few opportunities within the financial sector. For example, some 
banks deemed ―too big to fail‖—particularly if they pay dividends—provide excellent 
opportunities.  
 
Proposed Changes in Financial Portfolio 
 BAC: Increase holdings by 515 shares at $18.66 per share 
 GS: Increase holdings by 15 shares at $177.84 per share 
 USB: Increase holdings by 103 shares at $27.51 per share 
 NLY: Increase holdings by 501 shares at $17.23 per share 
 JPM: Buy 350 shares at $46.14 per share 
 NTRS: Buy 137 shares at $58.77 per share 
 BBT: Buy 415 shares at $34.05 per share  
 
 
                                                 
50 Leo, L.D., & THIRUVENGADAM, M. (2010, March 4). Beige book: economy is improving, but snow hit some 
areas hard.    
     Retrieved from 
http://online.wsj.com/article/SB10001424052748703862704575099740217465042.html?mod=WSJ_latestheadlines  
 Detailed Company Overviews  
 
Bank of America Corporation – INCREASE HOLDINGS 
Stock Symbol: BAC Market Capitalization: 179.57B 
Last Trade: 18.66 P/E (ttm): 7.9 
52 Week Range: 6.00 - 19.08 EPS (ttm): -0.03 
Dividend Yield: 0.22% Z-Score: N/A 
Beta: 2.40 Revenue From Abroad: N/A 
Recommended Holding Period: Long-term 
 
Bank of America was one of the first major banks to pay back TARP funds after 
the bailout by the U.S. government, which freed itself from exceptional federal 
oversight. The company has also managed to attain strong capital ratios and 
reserve adequacy while it was paying back funds borrowed from the government 
bailout programs.  Bank of America also has high exposure to improving consumer 
credit, which we believe makes for a sound investment.   
 
According to top Wall Street advisors, including David Katz of Matrix Asset 
Advisors, the price of Bank of America is expected to reach $30.00 up from its 
current price of $18.66.
51
 We are not overly concerned that BACs current price is 
near the top of its 52-week range. We believe the bank‘s 5-year range, reaching 
$55.08,is a more accurate view of the company‘s potential.  Stability for company 
earnings will come from Bank of America‘s exposure to diverse businesses. Bank 
of America grew through an aggressive series of acquisitions, including the 
purchase of Merrill Lynch for more than $50 billion, which transformed the bank 
overnight into the nation‘s largest player in wealth management.  
 
Our view of Bank of America parallels that of Tony Gray from Graybeard Capital, 
who believes that ―Bank of America has upside leverage.‖ Lastly, in the unlikely 
event of a double-dip recession, or if there is a shake-out in the financial sector, it 
is unlikely that Bank of America will be allowed to fail.  
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 Squawk on the street. CNBC, March 15, 2010. 
 67 
Goldman Sachs Group Inc. – INCREASE HOLDINGS  
Stock Symbol: GS Market Capitalization: 90.97B 
Last Trade: 177.84 P/E (ttm): 8.80 
52 Week Range: 99.55 – 192.75  EPS (ttm): 19.65 
Dividend Yield: 0.81% Z-Score: N/A 
Beta: 1.44 Revenue From Abroad: N/A 
Recommended Holding Period: Long-term 
 
Goldman Sachs is one of the few Wall Street titans that thrived during the financial crisis. 
Although Goldman Sachs took money from the U.S. government bailout programs, the company 
was one of the first major banks to repay all of its TARP funds, which shows the strength of the 
firm.  Other factors that show the continued strength of the bank are Goldman‘s consistent 
dividend payouts and its low P/E ratio.  Lastly, in the unlikely event of a double-dip recession, or 
if there is a shake-out in the financial sector, it is unlikely that Goldman Sachs will be allowed to 
fail.  
 
The Securities and Exchange Commission recently filed fraud charges against Goldman Sachs, 
alleging the Wall Street titan misled investors on securities linked to subprime mortgages. 
According to the Wall Street Journal, Goldman Sachs vigorously denied the SECs civil charges 
that the investment firm willfully deceived clients by selling them mortgage securities secretly 
designed by a hedge-fund firm run by John Paulson (Paulson & Co.).  Following the recent 
announcement by the SEC, Goldman‘s shares fell 13%, one of the steepest slides since the firm 
went public in 1999, erasing some $12 billion of market capitalization.
52
  
 
We believe that there was little wrong doing on the part of Goldman Sachs, and the lawsuit is 
about criminalizing financial sophistication and punishing size and success.  Once the case is 
tried, we believe Goldman Sachs will emerge victories. Therefore, our reaction to the SECs 
filings is to buy Goldman Sachs at today‘s fire-sale price.   
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US Bancorp– INCREASE HOLDINGS 
Stock Symbol: USB Market Capitalization: 49.84B 
Last Trade: 27.51 P/E (ttm): 27.14 
52 Week Range: 13.51 - 26.84 EPS (ttm): 0.96 
Dividend Yield: 0.77% Z-Score: N/A 
Beta: 0.96 Revenue From Abroad: N/A 
Recommended Holding Period: Long-term 
 
US Bancorp is one of the few banks that thrived during the financial crisis. Although US 
Bancorp took money from the U.S. government bailout programs, the company was one of the 
first major banks to repay all of its TARP funds, which shows the strength of the firm.  Also, in 
the unlikely event of a double-dip recession, or if there is a shakeout in the financial sector, it is 
unlikely that US Bancorp will be allowed to fail. 
 
Other indicators of the strength of US Bancorp are its consistent dividend payouts and forward 
P/E ratio. Even though banks, including US Bancorp, struggled to emerge from the recent 
recession, US Bank continued to pay a consistent dividend to investors. In the past two-years, the 
bank‘s dividend payout amounts were less than prior years; however, that is only to be expected. 
US Bancorp‘s high P/E ratio indicates a fair to high valuation of the stock. Additionally, 
analysts‘ consensus indicates sharply higher earnings with a forward P/E ratio (2011) of 11.26.  
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Annaly Capital Management, Inc. – INCREASE HOLDINGS 
 
Annaly Capital Management, Inc. is a real estate investment trust that buys government 
sponsored mortgage-backed securities. The company is known for its traditionally huge annual 
yield, and has the largest market capitalization of all REITS. Additionally, Annaly has a long 
track record of keeping well-regarded managers. The REIT trades for just over book value and 
will likely yield near 16% in 2010.
53
 Annaly‘s large annual yield, coupled with its low P/E ratio 
and solid management, makes this REIT a sound investment.  
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 http://www.forbes.com/2010/04/15/mortgage-reits-agency-markets-equities-annaly.html?partner=yahootix 
Stock Symbol: NLY Market Capitalization: 9.79B 
Last Trade: 17.23 P/E (ttm): 5.04 
52 Week Range: 11.76 – 18.75 EPS (ttm): 3.51 
Dividend Yield: 14.70% Z-Score: N/A 
Beta: 0.42  Revenue From Abroad: N/A 
Recommended Holding Period: Long-term 
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J.P Morgan – BUY 
Stock Symbol: JPM Market Capitalization: 172.63B 
Last Trade: 46.14 P/E (ttm): 20.10  
52 Week Range: 24.64 – 47.41 EPS (ttm): 2.24 
Dividend Yield: 0.44% Z-Score: N/A 
Beta: 1.13 Revenue From Abroad: Expected 
Recommended Holding Period: Long-term 
 
J.P. Morgan emerged from the 2008 financial crisis relatively unscathed, compared to many of 
its rivals, which positions it as a benchmark to gauge the health of the banking industry.
54
 
 
J.P. Morgan was one of the first Wall Street titans to pay back TARP funds borrowed during the 
recent government bailout. The bank‘s post-bailout strategy to increase its earnings power is 
beginning to pay off. According to John Race of DePrince, Race & Zollo, Inc., ―J.P. Morgan has 
more earnings power than they ever had before.‖ For example, the firm‘s investment banking 
division recently beat Goldman Sachs in fees earned, making it the number-one investment 
banking division in the business. Additionally, J.P. Morgan is also gaining market share in its 
capital market business and has the most exposure to improving consumer credit (approximately 
47% of credit costs).  In addition to growing its current divisions, J.P. Morgan is beginning to 
diversify its business demonstrated by its joint venture with the U.K.-based Cazenove Group 
Limited. 
                                                 
54
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Northern Trust Corporation – BUY 
Stock Symbol: NTRS Market Capitalization: 13.38B 
Last Trade: 58.77 P/E (ttm): 17.57 
52 Week Range: 46.21 – 64.72 EPS (ttm): 3.15 
Dividend Yield: 2.02% Z-Score: N/A 
Beta: 0.80 Revenue From Abroad: N/A  
Recommended Holding Period: Long-term 
 
Northern Trust Corporation, through its subsidiaries, provides asset servicing, fund 
administration, investment management, banking and fiduciary solutions for corporations, 
institutions, and individuals worldwide. Managers of Northern Trust have established a 
conservative stance in regard to growth and concentrate on organic growth within the firm.  
 
Unlike many of its rivals, the Chicago-based bank has made very few acquisitions in the last 
year, preferring to grow its assets organically. Additionally, the bank has shown more than 20% 
in asset growth in the past two years, and is currently looking to purchase a fund administer or 
asset manager. We believe Northern Trust is a smart investment at this time given its reasonable 
P/E ratio—with a forward P/E of 14.87—and a good annual dividend yield. Overall, Northern 
Trust is a high-quality bank with a strong dividend. 
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BB&T – BUY 
Stock Symbol: BBT Market Capitalization: 22.27B 
Last Trade: 34.05 P/E (ttm): 27.56 
52 Week Range: 15.32 – 32.93 EPS (ttm): 1.17 
Dividend Yield: 1.86% Z-Score: N/A 
Beta: 0.95 Revenue From Abroad: N/A  
Recommended Holding Period: Long-term 
 
BB&T is likely the strongest competitor of regional banks in the Southeast. The large regional 
bank has already paid back its TARP funds it borrowed during the recent recession. To its credit, 
BB&T has a conservative balance sheet, plenty of capital, and has diversified revenue sources, 
including insurance income. Additionally, BB&T is taking advantage of the recent recession to 
expand its market share by buying the assets of failed Colonial Bank. Company earnings are 
expected to double with a modest increase in revenue, according to numerous Wall Street 
analysts.  
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Summary of Portfolio Allocation Changes 
 
 
Holding No. of 
Shares As of 
4/12/10 
Proposed 
No. of 
Shares  
Mkt Value 
As of 4/12/10 
Proposed 
Mkt Value   
BAC 350 865 $5,936 $16,141 
GS 70 85 $12,331 $15,132 
USB 300 403 $7,851 $11,097 
NYL 670 1171 $12,006 $20,177 
JPM 0 350 $0 $16,141 
NTRS 0 137 $0 $8,070 
BBT 0 415 $0 $14,124 
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Uncertainty Looms 
 
The Crummer portfolio currently consists of six health care stocks: Covance, Johnson & 
Johnson, Merck, Perrigo, St. Jude Medical, and Stryker. The health care portfolio is well 
diversified and covers various sub-sectors of the health care sector. Covance is a drug 
development services company, Johnson & Johnson and Merck are both drug manufacturers, 
Perrigo sells OTC drugs, and St. Jude Medical and Stryker are both medical supplies companies. 
Currently, the biotech industry is not represented in the Crummer portfolio. Health care 
intelligence provider EvaluatePharma forecasts that seven of the top 10 drugs in 2014 would be 
biotech in origin. Also, with many drug manufacturers facing patent expirations in the next 3-4 
years, the OTC drug market is expected to grow much bigger. We decided to replace Perrigo 
with a similar OTC drug manufacturing company that has a greater potential to grow in the 
future. Hence, we decided to include Abbott, a well-diversified pharmaceutical and diagnostics 
company and Teva, a generic drug manufacturer in the portfolio.  
 
Demographic trend remains favorable 
The aging population, the lengthening of average life expectancy and a rising incidence of 
chronic diseases all favor positive growth in health care spending. The Centers for Medicaid and 
Medicare Services report that health care spending rose 5.7% between 2008 and 2009, while the 
GDP fell by 1.3% during the same period. Also, health care spending is projected to grow by 
6.1% on average this decade
55
. Further, IMS health, a health care consulting firm, expects US 
pharmaceutical sales to grow by 3%- 5% during 2010. In fact, Standard and Poor‘s predicts a 
much higher growth following the passing of the new health care bill.  
 
New strategies for tough times 
In 2009, Pfizer acquired Wyeth, Merck completed the acquisition of Schering- Plough and 
Roche acquired Genentech. Standard and Poor‘s believes that the major players in the industry 
chose to go the merger route to survive the looming patent expirations and other industry 
challenges. Morningstar predicts that this M&A activity would in fact intensify during 2010
56
. 
These mergers and acquisitions are predicted to greatly increase the number of drugs in the 
pipeline and decrease the R&D costs.  
 
Convergence of biotech and pharmaceutical companies 
The last two years also witnessed biotech and pharmaceutical companies converging towards 
each other. Major pharmaceutical have either acquired or partnered with biotech companies to 
mitigate their losses due to patent expirations. Biotech companies are slowly migrating towards 
biomarkers for cancer treatment. This should reduce the R&D costs and should enable 
identification of promising targets earlier in the process.  
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In spite of the positives, there are some uncertainties surrounding the health care industry in the 
near future. 
 
Looming patent expirations 
According to IMS health, the global pharmaceutical industry faces a cumulative loss of $137 
billion sales in the years 2009 through 2013, as generics encroach on a slew of patent- expired 
branded blockbuster drugs
57. But the industry‘s R&D pipeline, strengthened by the mergers and 
acquisitions, is strong and should drive the industry growth once it passes the high patent 
expiration years. 
 
Health care reform  
With the passing of the new health care bill, the Obama administration is planning to reduce 
skyrocketing health care costs, and invest in health information technology, prevention and care 
coordination. Though the pharmaceutical companies might be affected by price reduction, the 
companies could more than make up for reduced revenue through increased volume. My belief is 
that the pharmaceutical companies could gain more than they could lose because of the health 
care legislation.  
 
Although the demographic trends and the recent M&A activities favor the health care industry, 
there is still an uncertainty in how the pharmaceutical industry will react to the impending patent 
expirations and the new health care reform. But the situation is favorable to the biotech 
companies and OTC drug manufacturers who will greatly benefit from both the drug patent 
expirations and the new health care reform. Considering these factors, we decided to market 
weight the sector but increase the weight of the OTC drug manufacturers and biotech companies 
within the sector. 
 
 
 
 
 
 
 
Detailed Company Overviews  
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Covance, Inc – HOLD 
Stock Symbol: CVD Market Capitalization: 3.70B 
Last Trade: 61.18 P/E (ttm): 19.9 
52 Week Range: 32.31-61.59 EPS (ttm): 2.73 
Dividend Yield: N/A Z-Score:  
Beta: 1.00 Revenue From Abroad: 40% 
Recommended Holding Period: Short-term 
 
Covance Inc. is a drug development services company that provides early-stage and late-stage 
product development services primarily to the pharmaceutical, biotechnology, and medical 
device industries worldwide
58
. They are the leading supplier of clinical trial laboratory services, 
providing lab work for more than a third of all clinical trials worldwide. Founded in 1987, 
Covance is based in Princeton, NJ and has annual revenues of more than $1.7 billion. The 
company has offices in more than 25 countries, generating nearly 40% of its revenue outside the 
United States
59
. 
 
In 2008, the company announced a $1.6B 10-year collaborative agreement with Eli Lilly for 
contract research services.  Covance also purchased an early drug-development site from Lilly, 
expanding the firm‘s pharmacology capacity. Covance experienced a 5.6% growth in sales in the 
fourth quarter of 2009 from fourth quarter 2008 results. Morningstar estimates a 10% compound 
annual growth during the next five years
60
. There are no concerns surrounding the company‘s 
financial health – the company has no debt on their balance sheet and currently holds $266M in 
cash.  
 
With its global presence and broad service offering, Covance has positioned itself to take 
advantage of increasing drug-development outsourcing by pharmaceutical and biotechnology 
companies, particularly as stricter regulations of the drug development process come into play. 
At the same time, the company has significantly underperformed in the early-stage segment 
which has historically brought more than half the company‘s revenues. Also, because of the 
recent economic downturn, many pharmaceutical companies have decreased their R&D 
spending. This could adversely impact Covance‘s revenues. 
 
The long-term contract with Eli Lilly makes the company‘s stocks attractive but the projected 
decrease in pharmaceutical companies‘ R&D spending and lack of new major partners makes us 
maintain the same number of shares as in 2009.  
 
 
Johnson & Johnson – BUY 
Stock Symbol: JNJ Market Capitalization: 175.70B 
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Last Trade: 65.10 P/E (ttm): 13.00 
52 Week Range: 46.25 – 65.95 EPS (ttm): 4.63 
Dividend Yield: 3.20% Z-Score:  
Beta: 0.60 Revenue From Abroad: 49% 
Recommended Holding Period: Long-term 
 
Founded in 1885, Johnson & Johnson ranks as the world's largest and most diverse health-care 
company and controls the top or number-two leadership spot in 70% of its products. The 
company comprises three divisions: pharmaceutical, medical devices and diagnostics, and 
consumer. Its consumer segment, contributing approximately 25% of total sales, provides 
products used in baby care, skin care, oral care, wound care and women‘s health care fields as 
well as nutritional products.  
 
Johnson & Johnson‘s 2007 acquisition of Pfizer‘s consumer business further solidified Johnson 
& Johnson‘s position in this market. As of January 2010, the company‘s pharmaceutical 
segment, which contributes 40% of total revenue, has 23 drugs in the pipeline with more than 
nine potential blockbusters in late stage development or recently approved. The medical devices 
and diagnostics segment, bringing in 35% of sales, offers circulatory disease management, 
orthopedic joint reconstruction and spinal care and sports medicine, surgical care, and diagnostic 
products, as well as disposable contact lenses.   
 
These diverse businesses help the company maintain positive and strong cash flows. Strong cash 
generation has enabled the company to increase its dividend for the past 45 years. Despite the 
fact that the company faces more than $3B in patent exposure through 2010, experts predict that 
strong growth from the remaining business lines should offset these losses. After 2010, the 
company‘s patent exposure will be greatly reduced thereby setting up the company for steady 
growth
61
. 
 
As the baby boom generation ages, the entire spectrum of Johnson & Johnson's products should 
benefit from the increase in health-care needs. Also, by the end of 2009, the company had 
repurchased $8.9B worth of stocks as a part of its $10B repurchase program and plans to use the 
remaining $1.1B for repurchasing stocks in the near future. The firm reported a 9% increase in 
sales in 4
th
 quarter of 2009 as compared to the same period in 2008.  
 
Though the company faces significant patent expirations, it is well positioned for a solid long 
term growth. For these reasons, it would be prudent to purchase additional shares of Johnson & 
Johnson. 
 
 
Merck & Company, Inc – BUY 
Stock Symbol: MRK Market Capitalization: 116.6B 
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Last Trade: 38.30 P/E (ttm): 11.3 
52 Week Range: 20.05 – 41.56 EPS (ttm): 3.10 
Dividend Yield: N/A Z-Score: 
Beta: 0.80 Revenue From Abroad: 40% 
Recommended Holding Period: Long-term 
 
Merck & Company, Inc. provides products for human and animal health in the United States and 
internationally. Merck makes pharmaceutical products to treat conditions in a number of 
therapeutic areas, including cardiovascular disease, asthma, infections, and osteoporosis. The 
company also has a substantial vaccine business, with treatments to prevent hepatitis B and 
pediatric diseases as well as HPV and shingles. About 60% of the company's sales are generated 
in the United States
62
.   
 
The acquisition of Schering- Plough for $41B helped Merck to survive increased competition, 
patent losses, and a pipeline of drugs with poor chances of approval. Though Merck could lose 
Cozaar/Hyzaar in 2010 and Singulair in 2012 due to patent expirations, the acquisition of 
Schering has strengthened its pipeline as Schering faces only limited patent losses in the next 
few years. Also, this acquisition would generate cost savings of more than $3B by 2011. 
Morningstar estimates that the $4.5B Vioxx settlement would reduce more than 90% of the 
outstanding cases and the remaining could cost less than $1B. 
 
Though Merck needed an additional $8.5B in debt to finance the Schering acquisition, it is 
predicted that Merck‘s strong and stable cash flows should cut away the debt relatively quickly. 
Further, Merck‘s drugs posed a strong growth in the last quarter of 2009. Merck‘s new drugs 
Januvia (Diabetes), Isentress (HIV), and Saphris (Antipsychotic drug) continue to perform better 
in the last quarter of 2009. These new drugs together with the drugs in the pipeline should enable 
the company to increase long-term sales despite the patent expirations of Cozaar/Hyzaar and 
Singulair. 
 
Though the patent expiration of Cozaar/Hyzaar and the potential integration problems between 
Merck and Schering are significant, the fact that the merger could help achieve $3.5B in cost 
savings by 2012 and the possibility of potential blockbuster drugs in the pipeline makes the 
company‘s stocks more attractive. Hence, our analyst recommends a small increase in the 
number of stocks of Merck for this year‘s portfolio.  
 
 
 
 
 
Perrigo Company – SELL 
Stock Symbol: PRGO Market Capitalization: 4.5B 
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Last Trade: 51.13 P/E (ttm): 16.3 
52 Week Range: 18.54- 50.16 EPS (ttm): 1.87 
Dividend Yield: 0.60% Z-Score:  
Beta: 0.70 Revenue From Abroad: 29% 
 
Founded in 1887, Perrigo is the world's largest manufacturer of over the counter pharmaceutical 
products for the store brand market, supplying around 1200 private-label over-the-counter drugs 
and nutritional products to large pharmaceutical chains. The company operates through three 
segments – consumer health care, Rx pharmaceuticals, and API.  
 
Perrigo supplies two- thirds of store brand drugs and vitamins to pharmacies worldwide, which 
accounts for more than 80% of sales. It maintains this position by passing along the cost savings 
to customers such as Wal-Mart, Walgreens, and CVS.  Perrigo‘s Clay- Park subsidiary 
specializes in hard-to-make generic creams and ointments. The company expanded its offerings 
through the acquisition of Agis Industries in 2005. These businesses represent higher margin 
growth opportunities for Perrigo.  
 
With the growing trend of converting prescription drugs to OTC after patent expiration, Perrigo 
is set to gain even more. The company recently announced exclusive distribution rights for 
Prilosec OTC. According to Morningstar, this move could add $250M in sales in 2010 which 
could boost total revenue by over 15%. Also, Perrigo is already planning to launch an OTC 
version of Allegra-D when the patent expires in 2012. The company is greatly benefitting from a 
weak economy and people‘s preference for cheap, store brand pharmaceuticals.  
 
But the company uses substantial U.S. labor for manufacturing, and its gross margins could be 
vulnerable to a more efficient overseas competitor like Teva pharmaceuticals. And the 
company‘s operations are mainly located in United States and Europe which are not typically 
considered to be low-cost manufacturers. This means that a 10% reduction in prices could wipe 
out Perrigo‘s cash flow. Also, the entry of low- cost competitors like Dr. Reddy Labs could hurt 
the company‘s cash flow in the future. 
 
Also, because of the strong growth opportunities in the OTC market, we decided to invest in 
Teva pharmaceuticals in addition to Perrigo. Hence we recommend selling the shares of Perrigo 
and use the money to buy some shares of Teva pharmaceuticals. This move could help maintain 
the diversification and also improve the performance of Crummer health care portfolio. 
  
 
 
 
 
St. Jude Medical, Inc. – SELL 
Stock Symbol: STJ Market Capitalization: 13.1B 
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Last Trade: 39.85 P/E (ttm): 14.2 
52 Week Range: 31.24 – 41.96 EPS (ttm): 2.43 
Dividend Yield: N/A Z-Score: 
Beta: 0.80 Revenue From Abroad: 45% 
 
Founded in 1976, St. Jude Medical, Inc. designs, manufactures, and distributes cardiovascular 
medical devices including the world's most widely used mechanical heart valve, and implantable 
neurostimulation devices worldwide. It operates in four segments: Cardiac Rhythm Management, 
Cardiovascular, Atrial Fibrillation, and Advanced Neuromodulation Systems.  
 
The company markets its products through a direct sales force and independent distributors. The 
company earns more than 45% of its revenue from its sales abroad. This could further improve 
when St. Jude‘s manufacturing facilities become operational in Costa Rica and Malaysia in late 
2011. Overall, the medical supplies sub-sector has a positive outlook for the upcoming year. 
Morningstar expects 9% average annual growth through 2012. 
 
St. Jude was originally a pioneer in mechanical heart valves but has branched out with various 
acquisitions. For example, in 2008, cardiac rhythm management devices accounted for 74% of 
total sales. And the Angio-Seal device still maintains the market leadership in the $550M 
vascular closure market. But the company faces stiff competition in cardioverter defibrillator 
market (from Boston Scientific) and pacemaker market (from Medtronic). Also, advances in 
minimally invasive heart- valve repair could reduce the demand for traditional heart- valve 
replacements St. Jude‘s offers.  
 
Further, the recent economic downturn has led to tight budgetary constraints in the hospitals and 
it could greatly hamper St. Jude‘s profitability. But with the economy forecasted to improve and 
the new health care reform taking into effect in the near future, it will be prudent to reconsider 
this company in the following years. 
 
For the current period, our analyst suggests selling our shares in this company and distributing 
those assets to other companies within the health care portfolio. 
 
 
 
 
 
 
 
 
 
Stryker Corporation – BUY 
Stock Symbol: SYK Market Capitalization: 116.6B 
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Last Trade: 56.85 P/E (ttm): 16.7 
52 Week Range: 30.82 – 57.39 EPS (ttm): 2.77 
Dividend Yield: 1.10% Z-Score: 
Beta: 0.80 Revenue From Abroad: 34% 
Recommended Holding Period: Short-term 
 
Founded in 1941, Stryker develops, manufactures, and markets orthopedic implants and medical 
devices. It operates in two segments: Orthopedic Implants and MedSurg equipment. The 
orthopedic implants include multiple types of implant systems and the MedSurg equipment 
includes surgical equipment. The firm generates most of its revenue from reconstructive 
implants, such as knees and hips. Stryker also offers a wide range of operating room equipment 
and tools used for orthopedic and other procedures. Hospital beds, stretchers, and other hospital 
equipment account for the rest of Stryker's sales. 
 
Sales grew 7% year-over-year, driven primarily by 10% orthopedic growth and 2% MedSurg 
growth. The company remained highly profitable during the fourth quarter of 2009 generating 
$500M in free cash flow. Also, with $1B in debt offering, the company is sitting on about $4B in 
cash which could be used for share repurchases or for offering dividends.  
 
Also, 60% of the company‘s revenue comes from orthopedic implants. The favorable 
demographic trend and a high entry barrier make the company highly favorable. Also, the 
company is developing two artificial spinal disks, which could improve the company‘s prospects 
in the highly profitable spine business. But the health care reform could reduce the long term 
returns in Stryker‘s US operations. Purchases of big ticket items may be delayed until the 
economic outlook improves. In addition, many resource-rich firms compete with Stryker. If it 
does not stay near the top of the innovation curve, it risks losing customers to those rivals.  
 
With the economy forecasted to improve in the near future and with many innovative products 
under development, Stryker could perform better in the coming year. The increased sales in the 
last quarter of 2009 and the huge cash available for reinvestment are both positive signs for 
Stryker in the coming year. The different factors were weighed in and our analyst recommends a 
hold position for Stryker stock.  
 
 
 
 
 
 
 
 
Teva Pharmaceutical Industries, Ltd. – BUY 
Stock Symbol: TEVA Market Capitalization: 58.2B 
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Last Trade: 64.43 P/E (ttm): 14.6 
52 Week Range: 63.01-63.96 EPS (ttm): 4.50 
Dividend Yield: 1.1% Z-Score: 
Beta: 0.55 Revenue From Abroad: 30% 
Recommended Holding Period: Long-term 
 
Teva Pharmaceutical Industries Ltd. is among the top-20 global pharmaceutical companies in the 
world. The company is headquartered in Israel and above 80% of Teva‘s sales, which totaled 
US$13.9 billion in 2009, is in North America and Europe. Teva USA markets products from a 
wide range of therapeutic areas including cardiovascular, anti-infective, CNS, anti-inflammatory, 
oncolytic, antidiabetic, analgesic, dermatology, respiratory, and female health care
63
.  
Teva‘s performance plunged in 2007 as competitors like Mylan, Novartis Sandoz, and Watson 
gained substantial scale through cross- border consolidation. But, in 2008, Teva regained the top 
position in the market with the acquisition of Barr. According to Morningstar, this acquisition 
could have influenced Teva to lower its price compared to its competitors which in turn resulted 
in higher sales. In fact, Teva USA‘s 2009 revenue was 25% higher compared to 2008 revenue. 
Teva also acquired Sicor, a leading provider of hard-to-make injectable, and globally diversified 
Ivax. This acquisition helped Teva gain leadership in growth markets like Russia, France, and 
Mexico. 
One factor that distinguishes Teva from its competitors is that Teva manufactures more than 50% 
of its raw materials thereby reducing the manufacturing cost of its products. The recent 
acquisitions have allowed Teva to increase this percentage and the cost savings is in turn 
transferred to the customer. Product costs play a major role in determining sales in the generic 
drug market and Teva is predicted to lead the market in the near future.  
Copaxone, a multiple sclerosis therapy accounts for about one fifth of Teva‘s revenue and it is 
predicted to grow until 2014 when the patent expires. On September 2008, the FDA accepted for 
filing Mylan‘s abbreviated new drug application for a generic version of Copaxone64. It is still 
not clear why Mylan had entered into a license and supply agreement with NATCO, an Indian 
pharmaceutical company for distribution rights so early. According to Teva, Copaxone is a very 
complicated product and it would be difficult to replicate by any other manufacturer. Also, Teva 
has indicated that it is already looking for possible alternatives in the multiple sclerosis market. 
Taking into consideration all the above mentioned factors, our analyst predicts that investing in 
Teva is prudent and hence, maintains a buy position. 
Abbott Laboratories – BUY 
Stock Symbol: ABT Market Capitalization: 81.8B 
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Last Trade: 54.34 P/E (ttm): 13.6 
52 Week Range: 41.27 – 56.79 EPS (ttm): 4.20 
Dividend Yield: 3.0% Z-Score: 
Beta: 0.60 Revenue From Abroad: 54% 
Recommended Holding Period: Short-term 
 
Abbott manufactures and markets pharmaceuticals, medical devices, blood glucose monitoring 
kits, and nutritional health- care products. Products include prescription drugs, coronary and 
carotid stents, and nutritional liquids for infants and adults
65
. Following the acquisition of 
Advanced Medical Optics, Abbott also markets eye-care products. Abbott generates slightly less 
than 60% of revenue from pharmaceuticals. 
 
Abbott has a wide lineup of patent- protected drugs, a leading diagnostics business, a strong 
nutritional division and an emerging vascular group
11. Abbott‘s pharmaceutical division contains 
many blockbuster drugs including Humira, Kaletra, Tricor and Trilipix. Together these four 
drugs account for more than 26% of total sales. Humira, an autoimmune agent, grew by 20% in 
the past year. Humira could face significant competition from Pfizer‘s JAK-3 inhibitor which has 
shown strong efficacy in Phase II trials. Trilipix, used for cardiovascular treatment, is expected 
to grow much higher in the next few years.  
 
In addition to the pharmaceutical division, Abbott runs top-tier diagnostic and nutritional 
segments that generate more than 30% of total sales. This could potentially help the company if 
the pharmaceutical division faces patent expirations in the coming years. Recently Abbott 
launched Xience, a drug coated stent used to treat coronary heart disease. The clinical trials for 
Xience are positive and experts believe that Xience could outperform Medtronic‘s Endeavor, the 
market leader.  Also, Abbott does not have any major patent expiration in the near future.  
 
Abbott‘s acquisition of Solvay‘s pharmaceutical units has increased the drugs in the pipeline, 
many of which have a potential to become blockbuster drugs. But, overall, the company does not 
have a large number of drugs in the pipeline compared to its rivals. This could be a major 
problem unless the company expands its drug pipeline either by R&D or by acquiring other 
biotech companies. 
 
Overall, Crummer health care portfolio could be more diversified if we invest in a company like 
Abbott which in turn has a much diversified business. Hence, we decided to include Abbott as a 
part of Crummer portfolio. 
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Summary of Portfolio Allocation Changes 
 
Holding No. of 
Shares As of 
4/12/10 
Proposed 
No. of 
Shares  
Mkt Value 
As of 4/12/10 
Proposed 
Mkt Value   
JNJ 400 500 $26,040 $30,555 
PRGO 550 0 $28,122 $0 
STJ 200 0 $7,970 $0 
SYK 150 150 $8,528 $8,646 
MRK 100 150 $3,830 $5,528 
ABT 0 125 $0 $6,529 
TEVA 0 125 $0 $7,896 
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Want a Tech bargain? Head to Wal-Mart. 
 
As a general recommendation, the tech sector should be underweighted, at least for the next year. 
Having stated this, we would also recommend buying, or holding, companies that may benefit 
from the proliferation of mobile technology in the coming years. We feel that this is the best way 
to exploit the value that still remains in the tech market. 
 
We recommend underweighting the tech sector because:  
 Any perceived value may already be built into current prices 
Tech stocks have seen somewhat of a revival since March 2009. While this revival can be 
taken as a sign of optimism, it can also indicate that any good feeling towards these 
stocks for the coming year is already built into the price. This in-built value makes tech 
stocks, in general, poor value at current prices. Additional evidence that the tech sector is 
at least fair value can be seen in the historical performance of the sector. The S&P Tech 
sector has seen a -8.37% return annualized over 10 years, and in the previous year alone, 
has seen a 64% gain. This would suggest that a correction may be likely in the sector to 
align returns with historical levels.
66
 
 
 Spending on tech is need based rather than driven by tech advancement 
The tech sector has always been about the next big innovation and having the most up to 
date hardware, software, or device available. In the current economic climate, this sector 
is driven less by what consumers and businesses want, and more by what they need. This 
view is supported by the NetAdvantage software sector report which states that 
―corporate buyers are taking a holistic view of their investment in software, evaluating 
not only the initial cost of the software, but also the long-term cost of support and 
viability of the vendor‖.67 This highly scrutinized and necessity based spending has 
resulted in a reduction in discretionary dollars in the tech sector as consumers and 
business hold off on buying what they desire and either only buy what they need, or 
alternatively, make do with what they have. With the variables that feed into the equation 
of discretionary spending, such as unemployment, expected to improve at a restricted rate 
at best, there seems to be no dramatic increase in tech spending on the horizon. 
 
Having looked at the downside of the tech sector in general, it is important that this generalized 
view can be overridden by certain catalysts that elevate expectations for certain subsectors or 
companies above the sector as a whole. We have identified one such catalyst that may propel 
certain market participants within the tech sector to higher returns than the sector as a whole: 
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67 NetAdvantage Software Industry Report 
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 Mobile Devices – Mobile devices are growing in popularity and their increased use 
can be expected to have a threefold effect on the tech sector. 
 
1) It is expected that over 200 million devices will ship in 2010. While the increase in sales 
volume is partly down to a reduction in price point, this additional volume will far 
outweigh any concerns about margins. This higher sales volume will benefit handset 
manufacturers. 
2) The Semiconductors that power these devices will be in high demand due to the increased 
sales. This is a great opportunity for chip manufacturers who are capable of providing the 
specialized hardware that power these devices.  
3) As more consumers are provided with information on, and work with, mobile devices, the 
market for mobile advertising will grow. In 2009, sales in this area were just under $1 
billion and this is expected to grow to $13 billion by 2013. This will provide a great 
source of income for the likes of Yahoo, Google, Microsoft, or any company that has a 
sizable amount of income from online advertising. 
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Detailed Company Overviews  
 
CISCO Systems Inc. – BUY 
Stock Symbol: CSCO Market Capitalization: 148.18B 
Last Trade: 25.88 P/E (ttm): 24.91 
52 Week Range: 15.25-26.48 EPS (ttm): 1.05 
Dividend Yield: N/A Z-Score: 4.105 
Beta: 1.2116 Revenue From Abroad: 46% 
Recommended Holding Period: Long-term 
 
Cisco Systems designs, manufactures, and sells Internet Protocol (IP)-based networking and 
other products relating to the communications and information technology industry worldwide. 
The company offers routers that interconnect IP networks and moving information between 
networks; switching systems, which provide connectivity to end users, workstations, and servers; 
application networking solutions; home networking products, such as voice and data modems, 
network cards, media adapters, Internet video cameras, network storage, and USB adapters; and 
Cisco security solutions to protect information systems.  
 
There can be some optimism regarding a spending recovery in IT that would reflect value in 
CISCO stock at the current price. CISCO is aligning itself with the right technologies, notably 
video conferencing and collaboration, which should enable the company to take advantage of the 
main tech trends developing over the course of the next 3 years. Also, the recent announcement 
to push for greater broadband speeds should benefit CISCO as it is one of few companies ready 
with routers that can handle the increased speed. For these reasons, it is recommended that the 
current holding in CISCO is added to and that the company should be viewed as a long term 
investment. 
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INTEL Corporation – BUY 
Stock Symbol: INTC Market Capitalization: 117.5B 
Last Trade: 21.27 P/E (ttm): 27.48 
52 Week Range: 14.14 – 21.55 EPS (ttm): 0.77 
Dividend Yield: 2.7% Z-Score: 8.140 
Beta: 1.1667 Revenue From Abroad: 43% 
Recommended Holding Period: Long-term 
 
Intel Corporation designs, manufactures, and sells integrated circuits for computing and 
communications industries worldwide. It offers microprocessor products used in desktops, 
nettops, workstations, servers, embedded products, communications products, notebooks, 
netbooks, mobile Internet devices, and consumer electronics, as well as in embedded designs, 
such as industrial equipment, point-of-sale systems, panel PCs, automotive 
information/entertainment systems, and medical equipment. In addition, it offers platforms that 
include a microprocessor, chipset, and enabling software to incorporate various components and 
technologies. Intel sells its products primarily to original equipment manufacturers, original 
design manufacturers, PC and network communications products users, and other manufacturers 
of industrial and communications equipment.  
 
Pent up demand for Intel‘s main semiconductor offerings combined with manufacturing 
efficiency improvements contribute to Intel looking like a solid long term buy at the current 
price. For this reason, the current holding should be added to modestly. 
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Microsoft Corporation – BUY 
Stock Symbol: MSFT Market Capitalization: 256.71B 
Last Trade: 29.27 P/E (ttm): 16.13 
52 Week Range: 16.18 – 31.50 EPS (ttm): 1.62 
Dividend Yield: 1.8% Z-Score: 4.873 
Beta: 0.9827 Revenue From Abroad: 72% 
Recommended Holding Period: Long-term 
 
Microsoft provides software products for computing devices worldwide. Its Client segment 
offers Windows product family that comprises Windows Vista; Windows XP Professional and 
Home; Media Center Edition; Tablet PC Edition; and other Windows operating systems. The 
company‘s Server and Tools segment provides integrated server infrastructure and middleware 
software that support software applications and tools built on the Windows Server operating 
system. It‘s Entertainment and Devices Division offers the Xbox video game system, including 
consoles and accessories, third-party games, games published under the Microsoft brand, and 
Xbox Live operations. This division also provides Zune digital music and entertainment device; 
PC software games; online games; Mediaroom, an Internet protocol television software; mobile 
and embedded device platforms; and Surface computing platform.  
 
According to Valueline, there is a good chance that business will undertake a software 
replacement cycle towards the end of 2010. If this is the case, Microsoft‘s Windows 7 and Office 
2010 offerings should be positive income generators for the company. Microsoft is also well 
poised to take advantage of the mobile technology boom, although the impact of this will not be 
seen until the 3-5 year horizon. For these reasons, the recommendation is to add moderately to 
the current holding and for the stock to be viewed as a long-term investment. 
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IBM Corporation – HOLD 
Stock Symbol: IBM Market Capitalization: 166.19B 
Last Trade: 127.94 P/E (ttm): 12.78 
52 Week Range: 89.29 – 134.25 EPS (ttm): 10.01 
Dividend Yield: 1.7% Z-Score: 2.846 
Beta: 0.8152 Revenue From Abroad: 65% 
Recommended Holding Period: Long-term 
 
International Business Machines Corporation (IBM) develops and manufactures information 
technology products and services worldwide. Its Global Technology Services segment offers IT 
infrastructure and business process services, such as strategic outsourcing, integrated technology, 
business transformation outsourcing, and maintenance. The company‘s Global Business Services 
segment provides professional services and application outsourcing services, including 
consulting and systems integration, and application management. Its Systems and Technology 
segment offers computing and storage solutions, including servers, disk and tape storage systems 
and software, semiconductor technology and products, packaging solutions, engineering and 
technology services, and retail store solutions. IBM‘s Software segment primarily offers 
middleware and operating systems software comprising WebSphere software for Web-enabled 
applications. 
 
Upgrades in the business market are more likely to come in the form of software rather than 
hardware, and IBM should benefit from this. These upgrades should generate additional income 
for IBM in the next 12 months and when combined with internal cost cutting measures should 
result in a healthy bottom line. The uncertainty over when hardware purchases will pick up 
prevents a more bullish recommendation for IBM, as a portion of the company‘s business is 
generated in this area, and therefore the current holding should be maintained. 
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Flextronics International Ltd. – SELL 
Stock Symbol: IBM Market Capitalization: 6.01B 
Last Trade: 7.39 P/E (ttm): N/A 
52 Week Range: 2.32 – 7.97 EPS (ttm): -7.41 
Dividend Yield: N/A Z-Score: 2.405 
Beta: 2.4097 Revenue From Abroad: 67% 
 
 
Flextronics International provides design and electronics manufacturing services to original 
equipment manufacturers of a range of products in infrastructure; mobile communication 
devices; computing; consumer digital devices; industrial, semiconductor, and white goods; 
automotive, marine, and aerospace; and medical devices markets. Its services include printed 
circuit board (PCB) and flexible circuit fabrication; and systems assembly and manufacturing, 
including enclosures, testing services, materials procurement, and inventory management. The 
company also offers design and engineering services comprising user interface and industrial 
design, mechanical engineering and tooling design, electronic system design, and PCB design. 
 
Many of Flextronics largest customers are struggling. Companies such as Motorola and Sony 
Ericsson are finding it tough in the mobile sector. As Flextronics relies heavily on these larger 
customers, they are a risky proposition. Flextronics should have a better 2010 than 2009, but not 
enough upside exists for a buy, or even a hold recommendation on the stock.  
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Computer Sciences Corporation – BUY 
Stock Symbol: CSC Market Capitalization: 8.21B 
Last Trade: 53.45 P/E (ttm): 8.75 
52 Week Range: 34.16 – 58.36 EPS (ttm): 7.31 
Dividend Yield: N/A Z-Score: 2.290 
Beta: 1.0246 Revenue From Abroad: 38% 
Recommended Holding Period: Long-term 
 
Computer Sciences offers what it believes is a broad array of services to clients in the global 
commercial and government markets. The company specializes in the application of complex 
information technology (IT) to achieve the strategic objectives of its customers. Offerings 
include IT and business process outsourcing, and IT and professional services. 
 
Outsourcing involves operating all or a portion of a customer's technology infrastructure, 
including systems analysis, applications development, network operations, desktop computing, 
and data center management. CSC also provides business process outsourcing, which involves 
managing key functions for clients such as claims processing, credit checking, logistics, and 
customer call centers. 
 
CSC has had a relatively good 2009 in terms of new contract awards. This leaves the company 
with a healthy balance sheet and a good backlog of work. At the current price, CSC seems 
undervalued and a P/E of 8.75 supports this conclusion. According to Valueline, CSC is also a 
ripe target for acquisition which shows its attractiveness to other players in the market. The trend 
towards IT outsourcing is also helping CSC to increase revenue. It is recommended that the 
stability and future potential of CSC would be an excellent addition to the portfolio. 
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Accenture
68
 – HOLD 
Stock Symbol: ACN Market Capitalization: 26.26B 
Last Trade: 42.40 P/E (ttm): 17.48 
52 Week Range:26.33 – 43.89 EPS (ttm): 2.38 
Dividend Yield: 1.80% Z-Score:4.793 
Beta: 0.72 Revenue From Abroad: 64% 
Recommended Holding Period: Long-term 
 
Accenture operates as a management consulting, technology services, and outsourcing company. 
Its management consulting services include customer relationship management; finance and 
performance management, strategy service line that helps clients turn insights into results; and 
supply chain management.  
 
Accenture also provides various system integration and technology services, such as enterprise 
solutions and enterprise resource planning, information management services, service-oriented 
architecture, custom solutions, software as a service, mobility solutions. Furthermore, Accenture 
offers IT consulting services in IT strategy and transformation, enterprise architecture, 
infrastructure and security consulting, application portfolio optimization and renewal, research 
and development, and digital solutions.  
 
As outsourcing of the IT function becomes more commonplace, Accenture is well placed to take 
advantage of the additional revenue that can be generated due to this trend. This outsourcing 
trend should be seen in the short terms and for this reason we recommend holding the existing 
shares in Accenture 
 
 
 
 
 
 
 
 
                                                 
68 All information compiled from Morningstar, Yahoo! Finance, FinViz, and NetAdvantage 
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Automatic Data Processing
69
 – HOLD 
Stock Symbol: ADP Market Capitalization: 22.34B 
Last Trade: 44.24 P/E (ttm): 16.34 
52 Week Range: 33.26 – 45.22 EPS (ttm): 2.69 
Dividend Yield: 3.10% Z-Score: 1.813 
Beta: 0.61 Revenue From Abroad: 18.5% 
Recommended Holding Period: Long-term 
 
Automatic Data Processing provides technology-based outsourcing solutions to employers, 
vehicle retailers, and manufacturers. It operates in three segments: Employer Services, 
Professional Employer Organization Services, and Dealer Services.  
 
The Employer Services segment offers a range of human resource information, payroll 
processing, and tax and benefits administration products and services, including traditional and 
Web-based outsourcing solutions.  
 
The Dealer Services segment offers integrated dealer management systems and business 
management solutions to automotive, heavy truck, motorcycle, marine, and recreational vehicle 
retailers in North America, Europe, South Africa, and the Asia Pacific region.  
 
Like other holdings in the tech sector, ADP will benefit from the continuing trend to outsource. 
In addition its customer base differs from that of the other outsourcing companies held and this 
provides a certain level of diversification. 
                                                 
69 All information compiled from Morningstar, Yahoo! Finance, FinViz, and NetAdvantage 
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EMC Corp.
70
 – HOLD 
Stock Symbol: EMC Market Capitalization: 38.57B 
Last Trade: 18.56 P/E (ttm): 35.47 
52 Week Range: 10.91 – 19.04 EPS (ttm): 0.53 
Dividend Yield: N/A Z-Score: 3.496 
Beta: 0.97 Revenue From Abroad: 47% 
Recommended Holding Period: Long-term 
 
EMC Corporation develops, delivers, and supports information infrastructure technologies and 
solutions. The company‘s Information Storage segment offers networked information storage 
systems, networked attached storage, content addressed storage, or direct attached storage 
environment. EMC‘s Content Management and Archiving segment offers software, which 
optimizes business processes, as well as creates, manages delivers, and archives information 
from documents and discussions, e-mail, Web pages, images, XML, reports, records, rich media, 
and application data.  
 
The company‘s RSA Information Security segment delivers products, packaged solutions, and 
services to guard the integrity and confidentiality of information. This segment offers security 
product and services, such as enterprise identity and access management products, and 
encryption and key management software that enable companies to collect, monitor, analyze, and 
report on security event-related activity.  
 
EMC‘s expertise in the information security sphere should see the company fair well in the short 
term. As the move to paperless workplaces gathers pace, the storage and protection of valuable 
documents makes knowledge of electronic security a valuable commodity. Technology to secure 
data sent through wireless means will also be a growing area that the company can take 
advantage of. Given this information, it is recommended that EMC be held at its current level. 
 
 
                                                 
70 All information compiled from Morningstar, Yahoo! Finance, FinViz, and NetAdvantage 
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Hewlett-Packard
71
 – HOLD 
Stock Symbol: HPQ Market Capitalization: 122.88B 
Last Trade: 53.42 P/E (ttm): 16.13 
52 Week Range: 30.98 – 53.79 EPS (ttm):  3.32 
Dividend Yield: 0.60% Z-Score: 2.645 
Beta: 1.04 Revenue From Abroad: 64% 
Recommended Holding Period: Long-term 
 
Hewlett-Packard Company provides a range of products, technologies, software, solutions, and 
services worldwide. The company‘s Enterprise Storage and Servers segment offers storage and 
server products in industry standard servers, business critical systems, and storageworks 
offerings.  
 
HP‘s Services segment provides a portfolio of multi vendor IT services, such as technology, 
consulting and integration, and outsourcing services.  
 
The company‘s HP Software segment provides enterprise IT management software, information 
management and business intelligence solutions, and opencall solutions. Its Personal Systems 
Group segment offers a line of personal computers (PCs) consisting of commercial PCs, 
consumer PCs, workstations, handheld computing devices, digital entertainment systems, 
calculators and other related accessories, and software and services for the commercial and 
consumer markets.  
 
Like Intel, HP should be well placed to take advantage once the pent up demand in the tech 
sector releases. It is important to note, however, that HP will have more competitors for this new 
influx of business and this poses a potential risk. For that reason, HP should be held at its current 
level as the company does offer a potential upside even taking this risk into account. 
                                                 
71 All information compiled from Morningstar, Yahoo! Finance, FinViz, and NetAdvantage 
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Summary of Portfolio Allocation Changes 
 
Holding No. of 
Shares As of 
4/12/10 
Proposed 
No. of 
Shares  
Mkt Value 
As of 4/12/10 
Proposed 
Mkt Value   
FLEX 700 0 $5,677 $0.00 
CSCO 300 600 $5,306 $15,918 
INTC 300 530 $6,762 $11,946 
MSFT 300 550 $9,096 $16,676 
CSC 0 277 $0 $15,185 
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Now Is Not The Time…  
 
We recommend a substantial reduction in the portfolio‘s fixed-income holdings because the 
near-record steepness of the yield curve and the uncertain timing of rising interest rates by the 
Federal Reserve create a high risk for a significant loss of capital.  
 
The Yield Curve 
The near record steepness of the yield curve is a clear indicator for investors to reassess current 
investments in the bond market. Net U.S. Treasury fixed-income issuance was $190 billion in 
2009, and Morgan Stanley estimates it will reach $2.55 trillion in 2010. An increase in supply 
should lead to increasing yields. To the point, David Greenlaw, Morgan Stanley‘s chief fixed-
income economist, has a bearish forecast, predicting 10-year yields will touch 5.5% in 2010.
72
  
 
Rising Interest Rates 
During his testimony in front of Congress on February 24, 2010, Federal Reserve Chairman Ben 
Bernanke stated the Federal Reserve intends to keep rates extraordinarily low for an "extended 
period."  We believe the Fed will work to keep interest rates low, per Bernanke‘s testimony; 
however, we also believe an increase in interest rates is inevitable as the Fed drains liquidity to 
prevent inflation. According to Dan Fuss, manager of Loomis Sayles bond fund, bonds prices 
fall when interest rates rise. The Associated Press reports the fallout could be costly for investors 
who poured more than $400 billion into bond funds since the start of 2009.
73
 
 
Conclusion 
Our recommendation to underweight the fixed-income sector stems from near record steepness 
of the yield curve and the likelihood that the Fed will be forced to increase interest rates in 2010. 
Specifically, we recommend selling all current short- and long-term bond holdings, and 
purchasing $30,000 in Vanguard Inflation-Protected Securities (VIPSX). Our strategy should 
protect the portfolio against a significant loss of capital due to inflation and rising interest rates. 
 
Proposed Changes in Fixed-Income Portfolio 
 Sell all short- and long-term bonds.  
 Purchase 2,375 shares of Vanguard Inflation-Protected Securities (VIPSX) at $12.63 per 
share for $29,996.25. 
                                                 
72 http://www.bloomberg.com/apps/news?pid=20601009&sid=agXHcHY4QAbE 
73
 Carpenter,  D. (2010, February 26).  Get ready: interest rate hikes bring good and bad .  
Retrieved from http:/ /www.google.com/hostednews/ap/article/ALeqM5iz0wEG0mqAwwxBaiQ -
yTHEkz8bUgD9E3VFB80  
Fixed Assets 
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 Detailed Company Overviews  
 
Fidelity Government Income Fund – SELL  
Symbol: FGOVX   
Net Asset Value: 10.50 Net Assets: 5.7B 
Expense Ratio: 0.45% 
Average Duration: 4.67 yrs 
Average Maturity: 5.20 yrs  
Average Credit Rating: AAA  
Yield: 2.88% Morning Star Rating:  
We recommend selling all shares of FGOVX, which is currently held in the Crummer Portfolio. 
 
T. Rowe Price High-Yield – SELL 
Symbol: PRHYX   
Net Asset Value: 6.53 Net Assets: 6.9B 
Expense Ratio: 0.80% 
Average Duration: 3.33 yrs 
Average Maturity: 6.41 yrs 
Average Credit Rating: B 
Yield: 7.55% Morning Star Rating:  
We recommend selling all shares of PRHYX, which is currently held in the Crummer Portfolio. 
 
Vanguard Intermediate-Term Investment-Grade – SELL 
Symbol: VFICX  
Net Asset Value: 9.82 Net Assets: 13.8B 
Expense Ratio: 0.21%  
Average Duration:5.33 yrs 
Average Maturity: 7 yrs  
Average Credit Rating: A 
Yield: 4.87% Morning Star Rating:  
We recommend selling all shares of VFICX currently held in the Crummer Portfolio.  
 
Vanguard Long-Term Investment-Grade – SELL 
Symbol: VWESX  
Net Asset Value: 8.96 Net Assets: 7.9B 
Expense Ratio: 0.23% 
Average Duration: 12.10 yrs 
Average Maturity: 23.40 yrs 
Average Credit Rating: A 
Yield: 5.86% Morning Star Rating:  
We recommend selling all shares of VWESX, which is currently held in the Crummer Portfolio.  
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Vanguard Inflation Protected Secs – BUY 
Symbol: VIPSX  
Net Asset Value: 12.63 Net Assets: $27.6B 
Expense Ratio: 0.20%  
Average Duration: 4.24 yrs 
Average Maturity: 8.60 yrs   
Average Credit Rating: AAA  
Yield: 1.70% Morning Star Rating:  
 
The addition to providing inflation protection, Treasury Inflation-Protected Securities (TIPS) 
provide income consistent with investment in inflation-indexed securities. The fund invests at 
least 80% of assets in inflation-indexed bonds issued by the U.S. government. It may invest in 
bonds of any maturity, though the fund typically maintains a dollar-weighted average maturity of 
seven to 20 years. 
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Summary of Portfolio Allocation Changes 
 
Holding No. of Shares 
As of 4/12/10 
Proposed 
No. of 
Shares  
Mkt Value 
As of 
4/12/10 
Proposed 
Mkt Value  
FGOVX 3,548 0 $37,255  $0 
PRHYX 2,474 0 $16,079  $0 
VFICX 3,652 0 $50,361  $0 
VWESX 5,596 0 $49,744  $0 
VIPSX 0 2,375 $0  $29,996  
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Current Portfolio Allocation  
 
 
 
Proposed Portfolio Allocation 
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Visual Portfolio Allocation 
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Value at Risk (VaR) is a widely used risk measure of the risk of loss on a specific portfolio of 
financial assets. VAR calculates the maximum loss expected (or worst case scenario) on an 
investment, over a given time period and given a specified degree of confidence.  
We used the VaR method to determine the maximum amount of the portfolio, with a 1% 
probability, that we could lose over a one-year period, assuming markets are normal and there is 
no trading. 
Our findings: 
 VaR with current weights: 
  $614,439 
 VaR with proposed weights: 
  $579,468  
Therefore, although we are reallocating over $100,000 of the portfolio from fixed income to 
stocks, we are still reducing the VaR of the portfolio. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Value-at-Risk 
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 The z-score bankruptcy measure was initiated in 1968 by Edward Altman. While this 
multivariate analysis of ratios remains controversial, it can be used with 80-90% accuracy in 
identifying bankrupt firms. The z-score evaluates 22 variables related to leverage, coverage, and 
profitability, ending with a figure known as ―Z‖. If Z is less than 1.81, there is a high probability 
of bankruptcy. If Z is greater than 3, there is a low probability. Along with the score‘s high 
accuracy in predicting bankrupt firms, it is less than ten percent inaccurate in falsely identifying 
firms as potentially bankrupt. As such, we believed this was a worthwhile figure to add to 
company analysis for the portfolio.  
  
Appendix 1 : Z-Score  
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Sector Holding Buy/Sell 
Staples Sysco Corp Sell 250 shares 
Staples Procter & Gamble Co Sell 230 shares 
Technology Flextronics Intl Sell all shares 
Telecommunications iShares S&P Sell 100 shares 
Health Care Perrigo Co Sell 100 shares 
Health Care St Jude Medical Inc Sell all shares 
Industrials Caterpillar Inc Sell all shares 
Industrials General Electric Co Sell all shares 
Fixed Income Fidelity Government Income 
 
Sell all shares 
Fixed Income T. Rowe Price High-Yield Sell all shares 
Fixed Income Vanguard Interm-Term 
Investment-Grade 
Sell all shares 
 
Fixed Income 
 
 
Energy 
 
Energy 
 
Energy 
 
Vanguard Long-Term 
 Investment-Grade 
 
First Solar 
 
Chevron 
 
Clean Energy Fuels Corp. 
 
Sell all shares 
 
 
Sell all shares 
 
Sell 120 shares 
 
Sell 130 shares 
 
Staples CVS/Caremark Corp. Buy additional 200 shares 
Staples Church & Dwight Co Inc Buy 146 shares 
Technology Cisco Systems Inc Buy additional 400 shares 
Technology Intel Corp Buy additional 230 shares 
Technology Microsoft Corp Buy additional 250 shares 
Appendix 2: Proposed Trade List 
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Technology Computer Sciences Corp Buy 277 shares 
Telecommunications American Tower Corp Buy 130 shares 
Telecommunications Crown Castle International 
Corp 
 
Buy 103 shares 
Discretionary Amazon.com Inc Buy additional 75 shares 
Discretionary McDonald's Corp Buy additional 150 shares 
Discretionary Autoliv Inc Buy 75 shares 
Discretionary Hasbro Inc Buy 75 shares 
Health care Johnson & Johnson Buy additional 100 shares 
Health care Stryker Corp Buy additional 25 shares 
Health care Merck & Co Inc Buy additional 50 shares 
Health care Abbott Laboratories Buy 125 shares 
Health care Teva Pharmaceutical  
 
Buy 125 shares 
Industrials Jacobs Engineering  Buy additional 30 shares 
Energy Exxon Mobil Corp Buy additional 95 shares 
Financials 
 
Financials 
 
Financials 
J.P. Morgan Chase & Co 
 
Bank of America 
 
Goldman Sachs 
Buy 350 shares 
 
Buy 515 shares 
 
Buy 15 shares 
 
Financials Northern Trust Corp Buy 137 shares 
Financials 
 
Financials 
 
Financials 
BB&T Corp 
 
US Bancorp 
 
Annaly Capital Mgmt 
Buy 415 shares 
 
Buy 103 shares 
 
Buy 501 shares 
 
Fixed Income Vanguard Inflation-
Protected Secs 
 
Buy 2,375 shares 
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Utilities Vanguard Utilities ETF Buy additional 130 shares 
Materials Helmerich & Payne Inc Buy additional 20 shares 
Materials Monsanto Co Buy additional 17 shares 
   
   
   
   
 
